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Résumé 
Chez les patients asthmatiques, on retrouve un remodelage de la matrice 
extracellulaire des poumons, caractérisé par une augmentation du collagène ou fibrose de la 
couche sous-épithéliale des voies respiratoires. Le souffle, maladie inflammatoire 
chronique des voies respiratoires inférieures des chevaux matures, présente des similarités 
physiopathologiques avec l’asthme humain, incluant le remodelage. Ceci nous conduit à 
l’hypothèse que la fibrose de la couche sous-épithéliale pourrait être une composante des 
lésions pulmonaires chez les chevaux affectés, ce que notre étude avait pour objectif 
d’évaluer.  
Des biopsies pulmonaires périphériques réalisées par voie thoracoscopique ont été 
obtenues chez 5 chevaux témoins et 6 chevaux atteints du souffle, avant (T0) et après une 
stimulation antigénique de 30 jours avec du foin moisi et de la paille. Avant le début de 
l’étude, les sujets étaient en rémission clinique et ne démontraient aucun signe clinique de 
maladie.  Un examen microscopique des échantillons prélevés a été réalisé après traitement 
au picrosirius-rouge, colorant  spécifique des fibres de collagène. La surface du collagène 
de la couche sous-épithéliale a été mesurée et corrigée en fonction de la taille de la voie 
respiratoire en utilisant des techniques morphométriques standards.  
Les chevaux atteints de souffle ont une surface de collagène plus grande dans la 
couche sous-épithéliale (p<0.1) en comparaison avec les chevaux témoins.  La fibrose de la 
couche sous-épithéliale demeure inchangée chez les chevaux malades après la stimulation 
antigénique de 30 jours. À T0, la fibrose de la couche sous-épithéliale est associée 
positivement aux variations maximales de pression pleurale et à la résistance pulmonaire 
chez les chevaux atteints de souffle. 
Les résultats de cette étude suggèrent qu’une fibrose de la couche sous-épithéliale 
est présente dans les voies respiratoires périphériques des chevaux atteints de souffle et 
contribue au déficit de fonction résiduel pulmonaire observé lors de rémission clinique. 
 
Mots-clés: Souffle, obstruction récurrente des voies respiratoires, modèle animal, asthme, 
chevaux, poumons, fibrose de la couche sous-épithéliale, remodelage 
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Abstract 
Extracellular matrix remodelling is present in the human asthmatic lung, and is 
characterized by increased collagen or fibrosis of the subepithelial area of the airway.  
Heaves, a naturally occurring chronic lower airway inflammatory condition in horses 
shares aspects of pathophysiology with asthma, including features of airway remodelling. 
We thus hypothesize that airway fibrosis is a characteristic of remodelling in heaves. The 
aim of this study was to evaluate the presence of fibrosis in the subepithelial area of the 
peripheral airways of heaves-affected horses. 
Peripheral lung biopsies acquired under thoracoscopic guidance were obtained from 
5 control and 6 heaves-affected horses, both before (T0) and after a 30 day antigenic 
challenge with mouldy hay and straw. Prior to the study, diseased horses were in clinical 
remission and exhibited no clinical signs of disease. Obtained samples were 
microscopically examined using picrosirius-red, a collagen specific histological staining 
technique.  Collagen area in the subepithelial layer, e.g. the region between the airway 
smooth muscle and the epithelial layer was measured, and corrected for airway size using 
standard morphometric techniques.  
In comparison with controls, heaves-affected horses had an increased collagen 
content in the airway subepithelial area (p<0.1). No change in fibrosis of the subepithelial 
area was observed in diseased horses after the 30 day antigenic challenge. Peripheral 
airway subepithelial collagen at baseline was positively associated with maximal changes 
in transpulmonary pressure and pulmonary resistance in horses with heaves but not in 
controls. 
Results of this study indicate that fibrosis of the subepithelial area is present in the 
peripheral airways of heaves-affected horses, and may play a role in residual lung function 
deficits observed in diseased horses even while in clinical remission. 
 
Keywords: Heaves, recurrent airway obstruction, animal model, asthma, horses, lungs, 
fibrosis of the subepithelial area, remodelling. 
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INTRODUCTION 
 
Since the antique times, a chronically recurring, debilitating respiratory disease 
affecting the lower airways of equines has been described in stabled animals. Characterized 
by symptoms of respiratory distress during exacerbation, horses can nonetheless appear 
normal at pasture. The disease has been associated with a progressive loss of respiratory 
function and worsening of symptoms over years. More recently, a better understanding of 
heaves pathophysiology has revealed similarities with that of human asthma.  
Studies at the molecular and cellular level have led to the discovery of genes 
involved in disease manifestation, further justifying the use of the horse as a model for 
human asthma.  In asthmatics, the architectural changes which occur in the airway 
structures, collectively known as remodelling, limit the success of therapy. Such 
remodelling changes are not believed to be reversible and a better characterization of the 
latter in heaves may help target more appropriate therapies. Evidence suggests that airway 
remodelling may impair lung function, and lead to permanent deficits in baseline 
parameters.  
Remodelling of the different connective tissues of the lung, defined as the 
extracellular matrix, has been extensively studied in rodent models of human asthma.  An 
increase in collagen content is one of the well accepted features of extracellular matrix 
remodelling in these models. However, no studies to date have attempted to quantify these 
changes morphometrically in a naturally occurring model such as the horse. The objective 
of our study was the quantification of collagen content in the subepithelial region of the 
airways in heaves-affected horses and healthy controls.  The relationship between collagen 
content in the subepithelial region of the airway and lung function was also explored. 
The study of equine heaves thus serves a dual purpose in advancing scientific 
knowledge in both the veterinary and human medicine fields. 
2 
LITERATURE REVIEW 
1. Morphology and histology of the normal equine lung  
a. Introduction  
The equine lung is unique in its anatomic and functional characteristics. As opposed to 
other domestic species, in equines, both the right and left lung are composed of poorly 
divided cranial and caudal lobes, and the right lung also possesses a small accessory lobe 
(Parent, 1992). The lobes are divided into lobules, which in horses are well-defined but 
partially separated by abundant interlobular connective tissue (Tyler, Gillespie, & Nowell, 
1971). The lung is protected by thick connective tissue covering its surface called the 
pulmonary or visceral pleura. This layer is in continuation with interlobular tissue.  
Interestingly, human lungs share these same morphological characteristics (Magno, 1990; 
McLaughlin, 1983).  
 Three portions make up the respiratory system: the air-conducting bronchi and 
bronchioles, followed by a transitional portion, the respiratory bronchiole, and finally the 
gas exchange portion, comprised of the alveolar ducts, alveolar sacs and alveoli (Banks, 
1986).  
b. Bronchi, bronchioles and the alveolar structure 
The airway branching pattern in horses is considered monopodial, i.e. the parent 
bronchus yields asymmetrical daughter bronchi at different branching angles (Smith, et al., 
1994). This is in contrast to human airways, which tend to have a dichotomous branching 
system, where dividing bronchi are approximately symmetrical is size (Horsfield, Dart, 
Olson, Filley, & Cumming, 1971). 
Air enters the trachea, which at its bifurcation is called the carina, and yields the 
primary extrapulmonary bronchi (main bronchi). Once inside the lung parenchyma, these 
airways become the primary intrapulmonary bronchi, which then divide into secondary and 
tertiary bronchi.  Bronchi are airways greater than 2-mm in diameter and are surrounded by 
cartilage (McGorum, 2007). The bronchus is composed of a pseudostratified columnar 
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ciliated epithelium interspersed with the mucus-producing goblet cells (Pirie, Pirie, 
Cranston, & Wright, 1990). The number of goblet cells decreases, and the epithelium 
gradually changes to simple columnar as the bronchi become smaller. Adjacent to the 
epithelium and its basement membrane is the lamina propria, a layer of loose connective 
tissue composed of collagen, elastic fibers, other structural components and leucocytes.  
Together with the epithelium and its basement membrane, we refer to this part of the 
airway as the mucosa (Parent, 1992). Adjacent to the lamina propria, bundles of smooth 
muscle (lamina muscularis mucosa) are discernable and delimitate the beginning of the 
submucosa.  The submucosa is a vast region containing connective tissue, seromucous 
bronchial glands, blood vessels and nerves. In equines, bronchial glands are not present in 
the smallest bronchi.  Cartilaginous plates can be observed surrounding the submucosa, but 
are less evident as the bronchi branch and become smaller. The adventia is exterior to this 
hyaline cartilage and is an array of connective tissue that extends and blends into the lung 
parenchyma.  
Bronchioles are smaller airways devoid of cartilage (less than 2-mm in diameter), 
which are divided into primary, secondary, tertiary and respiratory bronchioles.  This 
terminology is based on morphological changes which occur as the bronchioles branch and 
decrease in size.  In contrast to the bronchi, bronchioles have no surrounding cartilage and 
do not possess submucosal glands.  A simple columnar epithelium is present in the primary 
and secondary bronchioles. In the tertiary bronchioles, the epithelium progressively shifts 
to a cuboidal configuration.  Goblet cells are usually not present in the bronchioles of 
normal horses.  Furthermore, ciliated cells become scarce in more distal airways and are 
absent in tertiary bronchioles. However, non-ciliated cells, also known as Clara cells, 
increase in the more distal airways (Pirie, et al., 1990).  It has been proposed that these cells 
play an important role in secreting protective substances for the airway epithelium and in 
detoxification of contaminants (Plopper, Mariassy, & Hill, 1980; Wong, Keating, & 
Waddell, 2009). The bronchiole epithelium and basement membrane are seated on the 
lamina propria.  This area is composed of a network of collagens, elastic fibers and other 
constituents which will be detailed further.  The lamina propria is then encircled by a 
smooth muscle layer which contributes to greater airway wall thickness than in the bronchi. 
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The submucosa and adventia merge together and are difficult to discern due to the absence 
of dividing cartilage. The submucosa and adventia of the bronchiole are composed of less 
collagen but contain a greater amount of elastic fibers than the bronchi. They surround the 
small airways, and are of similar composition to the lamina propria. Respiratory 
bronchioles are not very developed, if at all, in horses (McLaughlin, Tyler, & Canada, 
1961; Tyler, et al., 1971). An ultrastructural study of the distal equine airway describes a 
sudden junction between the tertiary bronchioles and the alveolar duct, with the absence of 
a connecting respiratory bronchiole (Pirie, et al., 1990). For the purpose of this paper, the 
region between the airway epithelium and smooth muscle will be subsequently referred to 
as the subepithelial layer or area. 
 
 
Figure 1  Equine bronchiole stained with Movat pentachrome histological dye, illustrating 
the different airway regions 
 
The alveolar duct is the extension of the respiratory bronchiole, or as previously 
mentioned, is continuous with the tertiary bronchiole in horses. It is of the same cellular 
composition as the alveolus and serves as a canal into which the alveoli empty (Tyler, et 
al., 1971).  It subdivides into the alveolar sacs, structures into which alveoli open.  Alveoli 
are hollow structures responsible for gas exchange; they are separated from one another by 
the alveolar septum, a network of capillaries and some connective tissue.  The cells which 
make up the alveoli are squamous epithelial cells, designated as type 1 pneumocytes, and 
cuboidal alveolar cells, designated as type II pneumocytes. Finally, alveolar macrophages 
 Smooth muscle layer    
Subepithelial area 
Airway mucus 
Airway epithelium 
Submucosa and Adventitia 
             Goblet cell 
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can also be found in between squamous epithelial cells and in the alveolar lumen.  Pores of 
Kohn are small holes sometimes present in the alveolar septa; their role is to allow air 
movement between alveoli.  The blood/air barrier is comprised of a thin layer of 
endothelium which lines the capillary, the basal lamina, and the type I pneumocyte. Type I 
cells comprise the medium for gas exchange while type II cells have a secretory and 
regenerative function, including the production of lung surfactant.  Type I and II cells lie on 
the basal lamina and a network of collagen, reticular and elastic fibers (Banks, 1986). 
c. Blood supply and innervation of the airway 
Blood supply to the bronchioles is provided by bronchial blood vessels which are 
distributed along the branches of the respiratory tree; upon reaching the end of the tertiary 
bronchioles, they become the capillary network communicating with alveoli.  Arteries 
closely follow the bronchial passages until the most peripheral airways.  However, 
particular to the equine species, while veins mostly follow the trajectory of the larger 
airways, they can also be found in the interlobular tissue (Dellaman & Brown, 1976; 
McGorum, 2007).  Similarly to humans, the bronchial artery also nourishes the pulmonary 
pleura and certain interalveolar septa (Tyler, et al., 1971).  It has been proposed that this 
particularity is to palliate perfusion problems of the alveoli in species with considerable 
lung parenchyma dorsal to the beginning of the pulmonary artery (Tyler, et al., 1971). 
Airway smooth muscle is innervated by visceral efferent fibers which follow the airway 
passages. These motor nerve fibers arise from thoracic and vagus segments of the 
sympathetic trunk.  The sympathetic nerves are responsible for bronchodilation while 
parasympathetic nerves cause bronchoconstriction (Dellaman, 1976).  
2. The extracellular matrix of the lung 
a. Introduction 
The connective tissues of the lung are important in maintaining the architecture and 
function of the bronchi and bronchioles, the pulmonary arteries and veins, the pleura, as 
well as the interalveolar septum. This connective tissue is composed of cellular elements in 
addition to extracellular matrix (ECM). The extracellular matrix can be defined as a 
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complex network of structural proteins intertwined together.  Its main components are 
fibrillar collagens and elastic fibers; however, proteoglycans and structural glycoproteins 
are also constituents of this complex network. Adhesive molecules such as fibronectin and 
tenascin can also be temporarily present in the ECM during development or regenerative 
processes (Chiquet-Ehrismann & Chiquet 2003). Its many important roles include 
structural support, tissue compartmentalization, and influencing cellular shape, function 
and interactions.  Recent evidence suggests the presence of growth factors, proteinases and 
proteinase inhibitors in the ECM (Greenlee, Werb & Kheradmand, 2007; Dunsmore & 
Rannels, 1996).  The altered presence and function of these factors could potentially have a 
role in ECM remodelling observed in respiratory diseases in various species.  In the 
bronchi and bronchioles, the matrix can be divided into the subepithelial matrix, the 
submucosal matrix, the smooth muscle matrix, the adventitial matrix as well as the 
cartilage matrix (bronchi only).  Finally, the alveolar wall possesses an interstitial matrix 
located between the fused epithelium and endothelium basement membranes (Parent, 
1992). 
b. Basement membrane 
The basement membrane is a particular form of ECM that is placed between a cellular 
element, such as the epithelium, and adjacent connective tissue.  In the airway, it underlies 
and supports the epithelium, mediates attachment of cells, and modulates the differentiation 
of epithelial cells. It is composed of three layers: the lamina lucida, the lamina densa and 
the lamina fibroreticularis.  The term basal lamina, or "true basement membrane", is often 
used to encompass both the lamina lucida and densa (Payne, et al., 2003). The lamina 
lucida is the layer closest to the epithelium and is of low electron density; it is bordered by 
the lamina densa, an electron-dense region.  The true basement membrane in humans is 
composed mostly of collagen type IV, laminin, enactin and proteoglycans (Dunsmore & 
Rannels, 1996). The lamina fibroreticularis is the layer in between the basal lamina and the 
adjacent lamina propria. In human asthma, the term subepithelial area or layer is used to 
designate this particular region of the airway (Roche, et al., 1989).  
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c. Collagen  
Collagen is a vital constituent of the extracellular matrix and is the most abundant 
fibrous protein present in mammals. It represents approximately 25% of total proteins and 
is secreted mainly by connective tissue cells such as fibroblasts (Alberts, 2008).  
Additionally, it can be synthesized by other cell types including smooth muscle cells, 
pneumocytes and endothelial cells (Parent, 1992).  This structural protein is primarily 
composed of three homologous polypeptide chains, known as α-chains, which are grouped 
together in a helical fashion.  A typical chain is composed of approximately one thousand 
amino acid residues which are aligned in a unique order. Important amino acids include 
proline, which serves to stabilize the helix because of its ring configuration, and glycine, a 
molecule which can inhabit the tight interior of the triple helix because of its small size and 
thus allow the α-chains to pack firmly together (Alberts, 2008; Last & Reiser, 1984; Minor, 
1980). 
Single α-chains are produced intracellularly as vast precursors termed pro-α-chains. 
These pro-α-chains have a collagenous central region and terminal amino and carboxy pro-
peptide units. These precursor molecules then undergo transformation; they are submitted 
to hydroxylation and glycosylation of end chain residues in the rough endoplasmic 
reticulum of the cell. Subsequently, three single α-chains assemble together to form a triple 
helical molecule and become procollagen. The procollagen is then secreted via exocytosis 
outside the cell, where the amino and carboxy propeptides are enzymatically cleaved to 
yield the collagen molecule, which will assemble with others to form a fibril. Finally, such 
fibrils may further combine to yield a collagen fiber (Alberts, 2008; Last & Reiser, 1984; 
Minor, 1980). 
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Figure 2  Schematic representation of collagen fiber synthesis1
 
  
Thus far, more than a dozen types of collagen have been identified in connective 
tissues, in addition to numerous different α-chain configurations (Dunsmore & Rannels, 
1996). Collagen types differ according to their charge, hydrophobic nature, the size and 
location of helical and non-helical domains and other structural properties (Last & Reiser, 
1984; Parent, 1992). Collagen fibers can further be divided into fibrillar and non-fibrillar 
collagens. Fibrillar collagens, such as types I, II and III, correspond to structural proteins 
initially assembled in a procollagen form as described above.  Conversely, non-fibrillar 
collagens are assembled differently; some types are resistant to proteolytic cleaving and 
others may be configured as small-chain collagens (Dunsmore & Rannels, 1996). 
The amount of collagen in a matrix is finely controlled and rests upon balanced 
mechanisms of production and degradation. Collagen degradation is performed by 
                                                 
1 Taken from and authorized by Berk et al. Molecular Cell Biology ʺIntegrating Cells into Tissuesʺ 22.3 
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activated collagenases, collectively known as metalloproteinases, which are secreted by 
multiple cell types including fibroblasts and phagocytic cells (Parent, 1992). These specific 
enzymes cause a disruption of the normal α-chain and allow consequent denaturation of the 
collagen triple helix by other proteolytic enzymes.  Changes in the immediate environment 
of the cellular ECM constituents can influence collagen degradation in the matrix and lead 
to abnormal synthesis of a different collagen type (Minor, 1980). 
Collagen is a structural protein which provides support to adjacent tissues and acts as a 
barrier to limit movement of other ECM components. It has the ability to resist tensile 
forces and limit excessive expansion, and provides a framework for cellular communication 
(Dunsmore & Rannels, 1996; Minor, 1980). The collagen molecule’s tensile strength can 
be attributed in part to the cross-linking architecture of the fibrils and the physical and 
chemical interactions with other ECM constituents (Minor, 1980). Collagen breakdown 
products have also been shown to influence cellular interactions in the ECM. These 
degradation peptide fragments result from proteolytic cleaving of collagen and can have 
similar structural features to chemokines and thus imitate their activity (Henson & 
Vandivier, 2006). A study by Weathington et al. (2006) has demonstrated that the 
acetylated tripeptide (N-acetyl Pro-Gly-Pro) is chemotactic for neutrophils and can recruit 
these inflammatory cells in the airways of mice. Furthermore, the peptide could induce 
remodelling changes in the lungs and heart of these mice if administered chronically by 
means of airway instillation. Furthermore, the collagen fragment’s actions were found to be 
mediated through a neutrophil CXC chemokine receptor (Henson & Vandivier, 2006; 
Weathington, et al., 2006). 
Collagen in the lung represents a minimum of 60% of the entire connective tissue 
protein (Parent, 1992). Type I and III collagen are the most abundant collagen types in the 
lungs of all mammals (Last & Reiser, 1984).  These collagen types are profuse in the 
interstitium of the lung; they are present in the subepithelial, submucosal and advential 
matrices, as well as the adventia of blood vessels, the alveolar septa, the pulmonary pleura 
and interlobular tissue (Parent, 1992). An early study on collagen distribution in the lung 
described type III collagen as being irregularly prominent in the alveolar septa and in the 
perivascular region of the lung. In this same study, type I collagen fibers were irregularly 
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dispersed in the interstitium of the alveolar septa (Madri & Furthmayr, 1980). Type II 
collagen is present in hyaline cartilage, such as found in tracheal and bronchi tissue and is 
normally absent in other parts of the lung matrix (Parent, 1992). The following table 
illustrates the anatomic distribution of collagen types in the lung. The subepithelial matrix 
is thought to possess a similar composition to that of the bronchial submucosa and 
adventia. 
 
Lung matrices Collagen Types 
Bronchial submucosa I, III,IV, V, VI 
Bronchial adventia I, III, VI 
Bronchial hyaline cartilage II, IX, XI?, VI? 
Airway smooth muscle I, III, IV, V, VI 
Alveolar interstitium I, III, V, VI, IV? 
 
Figure 3  Distribution of collagen types in the different lung matrices2
 
    
In equines, little is known about collagen distribution, type and quantity in the lung, and 
such information is inferred from other species.  One study performed in clinically normal 
adult racing Thoroughbred racehorses qualitatively assessed collagen content in sections 
from the caudal region of the lung. Picrosirius-red stain, a histological dye used to color 
collagen which will be detailed further in this paper, was used to assess the distribution, 
thickness and relative abundance of collagen in the lung parenchyma and small airways. 
Results suggested that in clinically normal racing horses, airway collagen in the caudal lung 
correlated with histological and radiographic alterations compatible with equine exercise-
induced pulmonary hemorrhage (Lakritz, et al., 1995). Nevertheless, these findings do not 
allow us to appreciate regional differences in collagen type or changes pertaining to other 
respiratory conditions in equines. However, a recent study further assessed collagen 
distribution in the equine lung (Furness, et al., 2010). Using an immunolabeling method, 
                                                 
2 Adapted from and authorized by (Parent, 1992) 
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the presence of collagen types I and III was demonstrated in the lamina propria and 
adventia of small airways in the lung tissue sections of normal horses. 
d. Elastin  
Elastin is another fibrous component of the ECM. This important structural 
hydrophobic protein is found in the lung and is present in the airway wall, alveolar wall, 
and blood vessels.  Amino acids that make up elastin assemble intracellularly; they are then 
secreted into the interstitial space where they further cross-link to one another. Elastic 
fibers are composed of elastin and microfibrils (fibrillin and micro-fibril associated 
glycoprotein) (Dunsmore & Rannels, 1996). Owing to their mechanical qualities, elastic 
fibers have the capacity to stretch and recoil the matrix of the lung (Dunsmore & Rannels, 
1996; Starcher, 2000).  Elastic fibers located in the alveolar septum allow considerable 
tissue elasticity in healthy lungs (Pelosi, Rocco, Negrini, & Passi, 2007). 
e. Proteoglycans and other ECM constituents 
Proteoglycans are part of the non-fibrillar component of the ECM. These 
macromolecules form a hydrated, gel-like film for the fibrous ECM proteins discussed 
above. Proteoglycans are comprised of a protein core (polypeptide chain) attached to 
glycosaminoglycan (GAG) side chains (Iozzo & Murdoch, 1996; Pelosi, et al., 2007).  
These glycosaminoglycans are heterogeneous polysaccharides and consist of repeating 
disaccharide molecules. The GAG side chains of proteoglycans can be divided into 
different classes based on molecular configuration properties such as sugar composition. 
There are four subclasses: hyaluronan, chondroitin and dermatan sulphate, heparin 
sulphate, and keratin sulphate (Willams, 2008).  Hyaluronan, a small GAG, differs from the 
other types in that its sugars are not sulphated (Pelosi, et al., 2007; Willams, 2008). 
Proteoglycans serve various functions in the matrix such as determining water content, 
resisting compressive forces and influencing matrix assembly.  Proteoglycans can bind to 
TGF-ß, a growth factor, and modulate its capacity to affect cellular proliferation and matrix 
deposition. Furthermore, proteoglycans such as decorin and biglycan can bind to collagen 
and thus alter fibril assembly (Pelosi, et al., 2007; Willams, 2008).   
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It is noteworthy that other adhesive-type molecules, such as fibronectin and laminin, are 
present in the matrix. These molecules facilitate cellular attachment to the matrix. 
3. Heaves (recurrent airway obstruction)  
a. Introduction 
Heaves, also known as recurrent airway obstruction (RAO) is a lower airway 
respiratory disease occurring in mature horses which results in chronic airway 
inflammation and obstruction following exposure to environmental antigens (Robinson, 
2001).  It is a frequent cause of loss of performance in the equine population. Although 
horses of various breeds and gender can be affected, a genetic predisposition for developing 
heaves has been demonstrated in Lipizzaners and Warmbloods (Gerber, 1989). Heaves is a 
condition typical of the Northern hemisphere, where the cold winter climate limits the use 
of outdoor pastures year round. Heaves is more likely to be diagnosed during the winter 
months when horses are housed inside (Couetil & Ward, 2003). 
b. Clinical manifestations 
In periods of clinical remission, while at pasture for example, heaves-affected horses 
can appear normal at rest.  However, they may still show signs of exercise intolerance and 
cough while ingesting food or exercising. During the acute phase of the disease, horses 
with heaves develop varying degrees of respiratory distress.  Affected animals may exhibit 
signs of dry cough, serous to mucopurulent nasal discharge, increased breathing effort and 
intolerance to exercise. In severe cases, horses can become emaciated and develop a "heave 
line" due to external abdominal oblique muscle hypertrophy. They may show signs of 
tachypnea, flaring of nostrils and extension of the head and neck, and perform a double 
effort at expiration (Beech, 2001). During an acute manifestation of heaves, horses will 
show a decrease in dynamic compliance and an increase in pulmonary resistance and 
arterial hypoxemia, and may develop airway hyperresponsiveness (Willoughby & 
McDonell, 1979). These changes result from periods of acute airway obstruction.  It has 
been repeatedly demonstrated that horses with clinical signs of heaves tend to improve 
when housed in a low dust environment, such as on outdoor pasture most of the day, and 
worsen when housed indoors on straw and hay (Grunig, et al., 1989; Lowell, 1964). The 
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clinical signs of heaves are thus reversible if appropriate environmental modifications 
and/or pharmacological therapy are used.  Heaves needs to be differentiated from 
inflammatory airway disease (IAD), a condition involving inflammation of the lower 
airways, but with absence of strenuous breathing while at rest (Couetil, et al., 2007). 
c.  Etiology and pathogenesis  
Chronic airway inflammation is central to the disease process in heaves. It is 
characterized by the presence of large amounts of neutrophils in the airway (Robinson, 
2001). However, the exact relationship between chronic distal airway inflammation and the 
clinical symptoms observed in heaves is still unclear. Numerous mechanisms can lead to 
the airway neutrophilia observed in heaves and have a contributing role in disease 
manifestation. 
A non-specific inflammatory response to inhaled moulds, yeasts, bacterial endotoxins, 
and noxious gases such as ammonia or methane are possible contributors to airway 
inflammation observed in heaves-affected horses. These pro-inflammatory agents can be 
found in the horse’s immediate environment when stabled indoors. Pirie et al. (2002) 
showed that beta-glucan, one of the components of the cell wall of moulds and other 
organisms, could contribute to airway inflammation if present in high quantity in hay-dust 
suspensions. Heaves-affected horses receiving the hay-dust suspension developed airway 
neutrophilia and airway obstruction as opposed to controls which developed only mild 
airway neutrophilia (Pirie, Collie, Dixon, & McGorum, 2002). Furthermore, bacterial 
endotoxins (LPS) inhaled experimentally can cause a dose-dependent airway neutrophilia 
in both diseased and control horses; however, airway obstruction is only evident in heaves-
affected horses. (Pirie, Dixon, Collie, & McGorum, 2001). Thus, these airborne irritants 
likely contribute to disease pathogenesis, but other mechanisms are also involved.  They 
are unlikely to be the primary cause of the disease as inhalation of beta-glucan or 
endotoxins at concentrations normally present in mouldy hay causes only mild airway 
obstruction in heaves-affected horses. 
It has long been proposed that an allergic-type reaction (hypersensitivity) to 
environmental antigens present in mouldy hay and straw is a more dominant contributor to 
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disease pathogenesis than the non-specific response briefly described above.  It is 
suggested that inhaled moulds and fungi are the basis of the allergens. The two agents most 
often involved in the disease process are Saccharopolyspora rectivirgula and Aspergillus 
fumigatus, both components of mouldy hay.  These agents have the capacity to cause 
airway obstruction in heaves-affected horses when inhaled, but not in healthy individuals 
(Derksen, Robinson, Scott, & Stick, 1988). The hypersensitivity reaction leads to airway 
inflammation which, as previously mentioned, is central to the disease process.  In Type I 
allergic respiratory diseases in humans and other species, a biphasic response can be 
observed in sensitized individuals.  The first is an early phase response which occurs 
minutes following antigenic exposure; it is mediated by the activation of cells bearing an 
allergen-specific IgE, such as mast cells.  When these cells are activated, pro-inflammatory 
mediators are released, which causes various responses in the airway and can lead to 
airway obstruction.  The second is a late phase response, occurring six to nine hours after 
antigenic exposure.  It corresponds to the time it takes for neutrophil recruitment and 
airway obstruction to take place. An earlier study by Fairbairn et al. (1993) revealed that, 
following antigenic exposure, neutrophils accumulated in the lungs of heaves-affected 
horses after four to five hours, resembling the late phase allergic response. However, rapid 
development of airway obstruction is not characteristic of the disease, and a recent study 
showed that heaves-affected horses nebulized with a hay-straw dust suspension did not 
develop significant changes in respiratory resistance or bronchoalveolar fluid histamine 
concentrations in the first twenty minutes of challenge (Deaton, et al., 2007). Therefore, the 
traditional type I hypersensitivity is not a main feature in the pathogenesis of heaves. It is 
presently not known whether the late phase response can occur without the initial first 
phase response.  
A type III hypersensitivity reaction follows the deposition of immune complexes in the 
lung and subsequent complement activation.  This type of hypersensitivity reaction requires 
a period of presensitization to a specific antigen. Horses with heaves have been shown to 
possess serum antibodies to certain bacteria, such as Saccharopolyspora rectivirgula and to 
certain moulds, such as Aspergillus fumigatus. However, these antibodies seem to be 
associated with the dusty stabling conditions more so than to the disease (Lawson, et al., 
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1979; Robinson, 2001).  Thus, a type III reaction is unlikely an important part of the 
pathogenesis. 
d. Pathophysiology 
Clinical manifestations of heaves result from airway obstruction caused primarily by 
bronchospasm. Nonetheless, airway inflammation, mucus accumulation, and airway 
remodelling are also contributors to this phenomenon. 
Bronchospasm can be defined as the abnormal contraction of the airway smooth muscle 
resulting in a narrowing of the lumen. Mediators of inflammation such as histamine 
(Derksen, et al. 1985), serotonin, and leucotriene D4 have been associated with acute 
manifestations of heaves (Olszewski, et al., 1999). These mediators act on the specific 
smooth muscle receptors in the airway and cause tension, contributing to 
bronchoconstriction (Robinson, 2001). However, they may not play a major role in 
bronchospasm in naturally occurring heaves per se, since antihistamines and leucotrienes 
antagonists are not effective at relieving clinical symptoms of heaves (Lavoie, et al., 2002). 
The bronchospasm observed in heaves-affected horses responds favorably to 
anticholinergic agents (Broadstone, Scott, Derksen, & Robinson, 1988) and beta 2-
adrenergic drugs, (Scott, Berney, Derksen, & Robinson, 1991) strongly suggesting that 
most of the response must be mediated through the muscarinic receptor.   It has also been 
suggested that a default in the inhibitory regulation of the airway smooth muscle 
contributes to the bronchospasm (Yu, Wang, Robinson, & Derksen, 1994). However, an 
altered beta-adrenergic receptor has been excluded as a possible culprit (Abraham, Kottke, 
& Ungemach, 2007). 
As previously mentioned, airway inflammation in heaves involves the accumulation of 
neutrophils in the airway lumen. When neutrophils are activated, they may release 
damaging mediators (reactive oxygen species, proteases, nitric oxide etc.) and pro-
inflammatory cytokines (TNF-alpha, IL-8 etc.) (Joubert, Silversides, & Lavoie, 2001). For 
example, the cytokine Interleukin 8 (IL-8) has been shown to be crucial to neutrophil 
recruitment and is overexpressed in the lungs of heaves-affected horses (Franchini, Gill, 
von Fellenberg, & Bracher, 2000; Franchini, et al., 1998). Therefore, persistent airway 
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neutrophilia and associated cytokine release is likely related to the airway obstruction 
observed, but the exact relationship between the two remains undetermined.  
Recent studies also suggest that heaves is associated with a dominating Th2-type 
cytokine response, as is observed in human asthma.  Interleukins IL-4 and IL-5, both Th2-
type cytokines, were shown to be overexpressed in mRNA of heaves-affected horses in 
comparison with controls (Cordeau, et al., 2004; Lavoie, et al., 2001). Furthermore, a study 
by Dewachi et al. (2006) showed that horses suffering from heaves have a greater number 
of neutrophils expressing receptors for certain Th2-type cytokines. This suggests that Th2-
type cytokines possibly modulate the neutrophilia observed in heaves and thus play an 
important role in overall pathogenesis.  However, these findings are not clearly established 
as others have failed to associate a Th2-type response with heaves (Ainsworth, et al., 2003). 
Cellular interactions being complex, other cell types likely play a role in pulmonary 
inflammation in heaves.  There is increasing evidence that macrophages, epithelial cells, 
mast cells, smooth muscle cells and others are all potentially involved in modulating airway 
neutrophilia. 
Mucus accumulation in the airways is another feature of the disease. Mucus is secreted 
by goblet cells that are interspersed in the superficial airway epithelium. It is a feature of 
most inflammatory lung diseases in horses caused by environmental irritants to the airway 
(Dixon, Railton, & McGorum, 1995).  Interestingly, while airway neutrophilia and 
bronchospasm can be controlled through environment modification, mucus tends to persist 
at higher levels than in controls, even during clinical remission (Jefcoat, et al., 2001).  
Mucus buildup is thought to be caused by increased goblet cell number and/or activity as 
well as reduction in clearance due to increased viscoelastic properties (Robinson, 2001). 
e. Gross pathology 
Macroscopic lesions in heaves are inconsistent. Equine lungs affected with heaves may 
appear normal or pale due to hyperinflation. As a result of hyperinflation, rib imprinting 
may be visible on the lungs (Beech, 1991).  Mucus often lines the trachea and major 
bronchi in varying amounts depending on disease severity.  Tracheobronchial lymph nodes 
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can be enlarged, and fibrinous pleuritis is sometimes observed (Winder & von Fellenberg, 
1988). Hypertrophied secondary respiratory muscles, more prominent bronchioles and an 
enlarged right ventricle, as a consequence of disease progression, are possible findings 
(Beech, 1991).  
f.  Diagnosis and therapeutics 
Heaves is usually diagnosed based on signalement, history and clinical findings. 
Airway neutrophilia can be confirmed with bronchoalveolar lavage cytology (›25% 
neutrophils present during exacerbation) (Robinson, 2001). The reversibility of the 
condition can be established by removing horses from the stable and placing them on 
pasture or by the use of bronchodilators or corticosteroids (Leguillette, 2003; Robinson, 
2001). 
The most crucial part of a therapeutic or preventative program for a heaves-affected 
horse involves the control of the environment. Removing the horse from the stable and 
pasture-boarding it year round is the best way to control airway inflammation and clinical 
symptoms. Practically, it can take a few days to months before clinical signs at rest are 
resolved. When it is not feasible to pasture the horse year round, clinical improvement may 
be obtained by low dust feeding and bedding (Leguillette, 2003).   
Corticosteroid therapy is considered the second line of treatment for heaves. Steroidal 
anti-inflammatory drugs act in many different ways on airway inflammation; they decrease 
gene transcription of pro-inflammatory cytokines known to be of relevance in human 
asthma, while also increasing transcription of anti-inflammatory genes (Alangari, 2010). 
They increase ß2-adrenoreceptor expression, preventing downregulation of these receptors 
(Barnes, 1997). Thus, they probably allow prolonged efficacy of ß2-agonists. Corticosteroid 
therapy can be administered systemically or by inhalation. Inhalation therapy reduces side 
effects; however, it is usually short acting, can become costly and can be difficult to 
manage for horse owners.  
Finally, bronchodilators may be used during acute episodes of respiratory distress to 
improve pulmonary gas exchange by relaxing the airway smooth muscles. They do not act 
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on airway inflammation and are thus more of a diagnostic tool or emergency medication 
(Robinson, 2001) and should not be used as sole therapy.  
4. Airway and alveolar changes in heaves 
a. Structural alterations 
i. Introduction 
Airway remodelling can be defined as the altered structure of cells and tissues in the 
airways of diseased animals in comparison with healthy individuals (Elias, Zhu, Chupp, & 
Homer, 1999). It is a well-known feature of human asthma and now recognized as also 
present in the airways of heaves-affected horses, as will be detailed in this section. It has 
been repeatedly documented that lung sections of heaves-affected horses tend to have 
noticeably thicker airways involving all the tissue layers than control airways (Herszberg, 
et al., 2006; LeBlanc et al., 1991). 
ii. Alveolar changes 
Electron microscopy studies have demonstrated that heaves-affected horses have a 
reduced number of capillaries and vascular endothelial cells, as well as the presence of an 
increased number of pores of Kohn in the alveolar lining. Moreover, diseased horses have 
an increased percentage of type II pneumocytes and decreased type I pneumocytes in their 
interalveolar septum (Gillespie & Tyler, 1969). 
iii. Airway epithelial and goblet cell alteration 
Structural alterations in the airway epithelium of heaves-affected horses have been 
profusely documented in the literature. For clarification purposes, cellular hyperplasia and 
hypertrophy refer to an increase in cell number and in cell size, respectively. Metaplasia 
refers to a form of less specialized cell type differentiation in response to chronic tissue 
injury.   
A number of studies have described hyperplasia of epithelial and goblet cells in the 
airways of heaves-affected horses (Breeze, 1979; Persson & Lindberg, 1991; Winder & von 
Fellenberg, 1987). Winder et al. (1987) reported that changes in epithelial and goblet cell 
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structure are already present in horses with mild disease. The hyperplastic and squamous 
metaplastic changes become more pronounced, occur in a greater number of airways, and 
are spread more diffusely throughout the lung in heaves-affected horses. In these same 
horses, goblet cell hyperplasia is highly prominent, affecting the entire bronchial tree, 
including some of the terminal bronchioles (Winder & von Fellenberg, 1988).  
Concurrently, another study involving a post–mortem histological analysis of heaves-
affected peripheral airways described hyperplastic changes in the epithelial layer, as well as 
increased apoptosis and desquamation (Kaup, Drommer, Damsch, & Deegen, 1990).  In the 
same report, goblet cells had evidence of metaplasia, which again appears to be more 
marked in horses with severe heaves. Other observations included a decrease in the number 
of Clara cells in mildly affected horses while in more severely affected individuals, Clara 
cells tended to be substituted by vacuolated cells (Kaup, et al., 1990). This same report 
described epithelial and goblet cell changes as being more prominent in the caudo-dorsal 
region of the lung (Kaup, et al., 1990). However, while the above study suggests uneven 
distribution of remodelling changes in the lung, Lugo et al. (2006) recently showed, using 
histomorphometric techniques, that no regional differences could be found in relationship 
to airway inflammation or to remodelling of the epithelium and mucus producing cells in 
the airways of heaves-affected horses.   
The exact mechanism by which these changes occur is unknown; however, as 
previously mentioned, non-specific airway inflammation can lead to epithelial/mucus cell 
remodelling. Irritants such as hay or stable dust are likely responsible for the increased 
number and secreting activity of goblet cells. Goblet cell metaplasia and the subsequent 
increase in mucus production contribute to a reduced lumen caliber in diseased horses and 
offer an explanation as to why lung function parameters are still slightly abnormal in horses 
in clinical remission. 
iv. Airway smooth muscle 
Airway smooth muscle hyperplasia and hypertrophy in heaves has been described 
qualitatively (Winder & von Fellenberg, 1987, 1988). Using quantitative morphometric 
techniques, a study by Herszberg et al. (2006) established that there is a nearly threefold 
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increase in airway smooth muscle mass (hyperplasia) in the airways of heaves-affected 
horses in comparison with healthy individuals. This change involved all airways but was 
most prominent in the smaller ones. The increase in airway smooth muscle mass is 
concurrent with augmented myocyte proliferation and apoptosis.  It has been suggested that 
the increased apoptosis serves as a compensatory response to airway smooth muscle 
hyperplasia (Herszberg, et al., 2006). Hypertrophic changes are also probable, as observed 
in human asthma (Ebina, et al., 1990; Hirst, et al., 2004), yet no quantitative analysis has 
been performed in heavy horses to date. The modified smooth muscle mass in diseased 
equines could contribute to airway obstruction by increasing muscle contraction strength 
and consequently causing narrowing of the lumen.   
v. Extracellular matrix 
A limited amount of information exists in the literature regarding structural changes in 
the pulmonary extracellular matrix in heaves-affected horses. Available material on the 
subject is generally limited to descriptive histopathology reports on heaves-affected horses. 
Furthermore, changes described are mainly those associated with the alveolar matrix or to 
the advential matrix peripheral to the bronchioles. 
A study reported that horses with generalized radiographic pulmonary patterns may 
have underlying structural and functional remodelling in the lung (Lakritz, et al., 1995).  
Some of the changes described are those of altered collagen deposition in the alveolar 
septa.  As horses with heaves generally have a bronchointerstitial pattern ( Robinson, 2001) 
on thoracic radiographs, the afore mentioned study suggests underlying remodelling could 
be at play. Kaup et al. (1990) reported a correlation between the degree of remodelling in 
the terminal airways and alveolar region of the lung with clinical severity of disease in 
heaves-affected horses, suggesting functional consequences of these changes. 
An early report by the same author, using brightfield and electron microscopy, reported 
that fibrosis was present in the alveolar region of moderate to severely heaves-affected 
horses. There was a marked increase in the number of collagen fibers in regions where 
inflammatory cells predominated. Lung fibrosis was even seen in less severely diseased 
animals; it was characterized by focally enlarged alveolar septa, due to an increase in 
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collagen, elastic fibers, and other connective tissues (Kaup, et al., 1990). Interestingly, even 
in severely affected horses, some regions of the lung were completely devoid of structural 
alteration. Similarly, another study also denotes thickening of the alveolar septa in heavy 
horses due to cellular infiltrates and fibrosis (Winder & von Fellenberg, 1988). 
An additional pathology report describes peribronchial and peribronchiolar fibrosis 
(fibrosis in periphery of the bronchial structure) as present in varying degrees of severity in 
five out of seven heaves-affected horses examined. Furthermore, in six out of seven 
controls, it was considered absent (Thurlbeck & Lowell, 1964). Unfortunately, none of 
these reports provided a quantitative assessment of ECM changes in the lung, and they did 
not differentiate between different components of the matrix. 
b. Comparing heaves with asthma 
Asthma is a chronic lower airway inflammatory condition in humans which resembles 
many aspects of disease etiology and physiopathology with heaves in equines. It is 
classically characterized as being an eosinophilic type inflammation of the airways 
associated with an upregulation of Th2-type cytokines (Murphy & O'Byrne, 2010). Airway 
eosinophilia is not observed in heaves-affected horses; however, as previously mentioned, 
there is increasing evidence indicating that Th2-type cytokines may contribute to the 
disease. Interestingly, it is now recognized that neutrophils are also significant contributors 
to airway inflammation in some subtypes of human asthma (Baines, Simpson, Scott, & 
Gibson, 2009).  
Moreover, human asthma shares similarities in airway remodelling with heaves. 
Increase in airway smooth muscle (ASM) mass in asthmatics is well-established, and 
characterized by myocyte hyperplasia and hypertrophy (Pepe, et al., 2005; Tagaya & 
Tamaoki, 2007). The ASM mass seems to increase concurrently with the degree of asthma 
severity, and migration of myocytes towards the epithelium follows this same tendency. It 
is believed that this migration of smooth muscle cells influences airway remodelling (Pepe, 
et al., 2005).  Myocyte migration towards the epithelium lining has not yet been described 
in heaves. 
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Epithelial and goblet cell alteration is another contributor to remodelling in asthma. 
Damaged epithelial cells produce pro-inflammatory mediators, such as TGF-ß, which are 
likely involved in the remodelling process (Tagaya & Tamaoki, 2007). Goblet cell 
metaplasia is seen in the airways of mild to severe asthmatics. The consequent increase in 
mucus production contributes to airway lumen narrowing and obstruction, as observed in 
heaves.  
Reticular basement membrane remodelling or subepithelial fibrosis is a characteristic 
feature of human asthma (Bai & Knight, 2005; Roche, et al., 1989; Tagaya & Tamaoki, 
2007). The "true basement membrane" is unchanged in asthmatics (Roche, et al., 1989), 
while the reticular basement membrane (RBM) is significantly thickened. This thickening 
is characterized by an increase deposition of collagens types I, III and V, as well as other 
ECM components such as tenascin, laminin and fibronectin (Payne, et al., 2003; Tran & 
Halayko, 2007; Wilson & Li, 1997). RBM thickening is not a feature described in heaves, 
as the basement membrane of equine airways cannot be properly visualized under 
brightfield microscopy. However, the lamina propria (area adjacent to and often merging 
with the reticular basement membrane) can be visualized in equine airways and evaluated 
with morphometric techniques.  
In asthma, remodelling changes in the subepithelial area are thought to arise as a 
consequence of prolonged airway inflammation and are believed to be partially responsible 
for eventual irreversible obstruction in patients with severe asthma (Nakagawa T, 2004).  
Studies have demonstrated that an increase in the degree of subepithelial fibrosis correlates 
with an increase in the severity of asthma (Benayoun, et al., 2003; Chetta, et al., 1997). 
However, others failed to identify a significant correlation between gravity of disease 
presentation and remodelling (Chu, et al., 1998; Pepe, et al., 2005).  
It has been proposed that RBM thickening serves as a protective mechanism for the 
airway by increasing the latter’s capacity to resist bronchoconstriction and thus decrease 
excessive narrowing (Lambert, Codd, Alley, & Pack, 1994; Niimi, et al., 2003). 
Nonetheless, subepithelial remodelling could also have a detrimental effect by increasing 
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airway wall stiffness and disturbing the dynamic balance between compressive and tension 
forces on the airway, leading to its collapse (Bento & Hershenson, 1998). 
 
Figure 4  Possible impacts of subepithelial remodelling on the airway lumen caliber 
 
Research further suggests that ECM has a role in modulating the functional properties 
of the airway smooth muscle cells.  In an in vitro study, ASM cells were adhered to ECM 
constituents to assess the mechanical response of the ASM cells to these matrix 
constituents.  Type I collagen caused an increase in the contractile strength of the ASM cell 
while response to other matrix constituents was different (Rodriguez, et al., 2009).  This 
study corroborates that ECM remodelling influences other processes in the airway.  
Many cytokines, growth factors, and other mediators have been shown to have 
fibrogenic properties and are likely linked to airway remodelling in asthma. TGF-ß, Th2-
type cytokines such as IL-5, -9 and -13, and VEGF have been associated with remodelling 
changes (Doherty & Broide, 2007). TGF-ß, a cytokine secreted by mesenchymal cells 
(fibroblasts, vascular and airway smooth muscle cells) and inflammatory cells (eosinophils) 
has been shown to play a crucial role in human asthma (Halwani, Al-Muhsen, Al-Jahdali, 
& Hamid, 2011). Indeed, the TGF-ß1 isoform has an increased expression in the airways of 
Protective mechanism: 
•Preventing airway narrowing by 
reducing the shortening of smooth 
muscle which is required to cause 
airway constriction 
 Subepithelial layer 
Detrimental effect on the airway: 
•Increasing airway wall stiffness and 
resistance to compression and 
tension, thus leading to airway 
collapse 
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asthmatics compared to controls (Minshall, et al., 1997). Increased concentrations of the 
latter have been associated with subepithelial collagen deposition (Makinde, Murphy, & 
Agrawal, 2007). Among its various functions, TGF-ß can induce the proliferation of 
fibroblasts and subsequent production of ECM components (Makinde, et al., 2007). As 
well, TGF-ß has the capacity to reduce collagenase production, thus altering normal 
collagen degradation in a matrix (Doherty & Broide, 2007). Nonetheless, a study 
comparing total TGF-ß1 isoform concentrations in bronchoalveolar lavage fluid samples 
between heaves-affected and control horses yielded no appreciative difference (Desjardins, 
et al., 2004). However, until its lung tissue expression has been evaluated, the contribution 
of TGF-ß in airway remodelling in heaves will remain uncertain. 
Since subepithelial changes in collagen content are important in overall pathogenesis of 
human asthma, we hypothesize that airway ECM remodelling will also be present in 
heaves. In support of this hypothesis, a study performed by our research group has shown, 
using suppression subtractive hybridization technique (SSH), that collagen type 1 alpha 2 
(col1A2) is over expressed in the heaves-affected horses. Furthermore, upregulation of this 
gene was confirmed using qPCR (Lefebvre-Lavoie, Lussier, & Lavoie, 2008).  An 
increased collagen content in the airway wall of heaves-affected horses would be a likely 
contributor to persistent airway function deficits in heaves, even after appropriate therapy 
with outdoor management and corticosteroid use. 
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Figure 5  Possible causative associations between airway inflammation, remodelling and 
disease manifestation in asthma3
 
.  
5. ECM histomorphometric techniques 
a. Introduction 
Histological sections can be qualitatively described for changes in patterns or structure 
of tissues. Such changes can be subjectively evaluated using a designed scoring system, 
based on severity of changes for example. However, spatial distribution and density of 
components are harder qualities for a person to subjectively assess.  Quantitative 
measurements of histological sections are thus necessary to better appreciate the latter 
tissue characteristics.  Such an evaluation has the advantage of being more objective and 
more easily reproducible by another evaluator. Quantitative measures can further be 
correlated to physiological and biochemical data, such as lung function parameters and 
inflammatory cell populations. The term "morphometry" can be used to designate a 
quantitative assessment of a given tissue component (Weiber, 1979).  
For histomorphometric studies, lungs must be carefully removed from the cadaver 
during necropsy to avoid lacerations of the visceral pleura, which could result in tissue 
damage (Dunnill, 1962). Post-mortem lungs are partially collapsed and hold little air, 
resulting in an unnatural microscopic appearance. Thus, re-expanding the lungs to 
approximate ante-mortem dimensions is desirable; this will mimic the intrapleural 
pressures present when the animal was alive. This can be achieved by inflating the lungs 
with gas and fixing them in formalin. Inflation by liquid infusion is also described but 
                                                 
3 Adapted from and authorized by “Airway Remodelling in Asthma”, Jack A. Elias, 2000 
Airway Remodelling 
•Subepithelial fibrosis 
•Goblet/epithelial cell alteration 
•Increase ASM 
 Chronic airway inflammation 
•Th2-type Cytokines 
•Clinical manifestations 
•Airway hyperresponsiveness 
•Fixed airway obstruction 
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results in greater artifacts than a gas instillation system (Dunnill, 1962).  Once expanded 
and fixed, lung sections can then be cut processed and preserved in paraffin to be evaluated 
at a future date (Weibel & Vidone, 1961).  
b. Staining protocols 
Numerous stains have been described in the literature for highlighting collagen and 
elastic fibers in various tissues. The considerable size of both these ECM proteins in 
addition to the weight of their molecular content allows a successful reaction to take place 
with the dye, leading to a useable scale for histological interpretation.  These staining 
protocols are of use in the evaluation of fibrous ECM components. However, they are less 
efficient for non-fibrous ECM constituents, given that their components can be accidentally 
removed while processing the given tissue or are often in too small quantity to be 
detectable (Parent, 1992). 
c. Collagen staining  
i. Picrosirius-red 
The need for more accurate collagen staining techniques resulted from the lack of 
specificity offered by traditional stains such as van Gieson and Masson’s trichome. Both 
these stains rely on a poorly-understood mechanism of differential binding, determined in 
part by size and structure of molecules. In addition to having a lower specificity, these 
stains lack the ability to color thinner collagen fibers, resulting in an inaccurate estimation 
of collagen content in tissues (Whittaker, Kloner, Boughner, & Pickering, 1994). The 
discovery of the picrosirius-red stain resulted from the work of Sweat et al. (1964). This 
research group showed that the Sirius red F3BA (color index 35780) could dissolve in a 
saturated solution of picric acid and repeatedly stain thinner collagen fibers.  As opposed to 
the van Gieson and trichome methods, the stain does not fade out and can be used under 
polarized light microscopy (Sweat, Puchtler, & Rosenthal, 1964). The picrosirius-red stain 
occurs through a reaction between the sulphonic acid groups of the dye and the basic amino 
groups of collagen at a low pH. Picric acid is required in order to obtain selectivity for 
collagen fibers although the mechanism resulting in the latter is unknown (Junqueira, 
Bignolas, & Brentani, 1979). 
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Picrosirius-red stain has been extensively used for histological analysis of collagen 
fibers in various organs and diseases. Myocardial collagen in rats (Whittaker, et al., 1994), 
dermal collagen in humans (Constantine & Mowry, 1968b), lung collagen in idiopathic 
interstitial pneumonia in people (Tzortzaki, et al., 2006) and thyroid neoplasms (Koren, et 
al., 2001) are examples of tissues or conditions for which the stain proved appropriate in 
histological evaluation. Furthermore, in lung tissue of asthmatics (Chu, et al., 1998) and in 
a murine model of the same disease (Corbel, et al., 2003), picrosirius-red was used 
successfully to quantitatively evaluate collagen content (subepithelial fibrosis). Finally, it 
has proved of use in evaluating lung collagen distribution (Lakritz, et al., 1995) and its 
morphometric assessment in horses with exercise induced pulmonary hemorrhage 
(Derksen, et al., 2009).   
 
Figure 6  Picrosirius-red staining under brightfield microscopy (Kiernan, 2007)  
 
ii. Polarized microscopy 
Collagen fibers can be visualized under polarized light due to their birefringence 
properties. Birefringence refers to the separation of light into two waves traveling at 
different speeds as it hits an object (Inoue, 2002). The colors (bright orange, yellow, red 
and green) observed under polarization are caused by a phenomenon called retardance. It 
corresponds to the "phase difference suffered by the two components of the orthogonally 
polarized light in passing through the crystal", or in the latter case, a collagen fiber (Inoue, 
2002).  
 Nuclei –  BLACK if stained (may be brown or 
grey) 
 
 Collagen – RED on pale yellow background  
 Cytoplasm –  YELLOW  
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The combined use of the picrosirius-red staining method and polarized light 
microscopy for the visualization of collagen fibers was first mentioned in the literature by 
Mowry et al. (Constantine & Mowry, 1968a). In the late 1970s and early 1980s, two 
Brazilian research groups further suggested this coloration be considered collagen specific 
with the use of polarized light (Junqueira, et al., 1979; Vidal, Mello, & Pimentel, 1982).  It 
was initially proposed that differences in color under polarized light corresponded to 
collagen types and thus allowed differentiation between types I, II and III (Junqueira, 
Cossermelli, & Brentani, 1978).  However, the same author later determined that difference 
in polarization colors was due to fiber thickness rather than type (Junqueira, Montes, & 
Sanchez, 1982).  Dayan et al. further established that the degree of packing of collagen 
molecules and fiber orientation also influenced the polarization colors microscopically 
observed. For example, this group demonstrated that more thickly-packed collagen 
molecules with better alignment exhibited a polarization color of a longer wavelength 
(Dayan, Hiss, Hirshberg, Bubis, & Wolman, 1989).   
 
 
 
Figure 7  Picrosirius-red staining under polarized light microscopy (Kiernan, 2007) 
d. Elastin and proteoglycan staining 
Elastin, another important large structural protein of the extracellular matrix of the lung 
can be evaluated by use of several stains, including Movat pentachrome. This histological 
stain will color elastic fibers black or dark purple and allow their visualization under 
brightfield microscopy (Parent, 1992; Russell, 1972). Our research group has used the 
 Large fibers collagen –  BRIGHT YELLOW or 
ORANGE (red) birefringence  
 
 Thin fibers collagen (including reticular fibers)  - 
GREEN birefringence 
 
 Some materials including Type 4 collagen in 
basement membranes, keratohyaline granules, and 
some types of mucus are stained RED but are not 
birefringent  
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Movat pentachrome stain successfully for elastic fiber visualization in the airways of 
heaves-affected horses (Lavoie, unpublished data). 
Alcian blue can be used as a histological stain for the evaluation of proteoglycans, 
GAGs and mucosubstances in a matrix (Parent, 1992). Using this dye, proteoglycans will 
appear blue under brightfield microscopy while other tissue elements will appear red to 
pink.  pH of the solution can be modified to allow more specificity for the polysaccharides 
put into evidence (Lev & Spicer, 1964). The reaction is based on an electrostatic attraction 
between the positive dye and the polyanionic glycosaminoglycan chain (GAG’s) (Lev & 
Spicer, 1964). 
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MATERIALS AND METHODS 
All experimental procedures were performed in accordance with the guidelines of the 
Canadian Council for Animal Protection. The project was further approved by the Animal 
Care Committee of the Faculté de Médecine Vétérinaire of the Université de Montréal. The 
experiment conducted for the subject of this paper was part of a larger research program 
pertaining to the roles of airway inflammation and remodelling in heaves and their possible 
reversibility. Procedures detailed in this section are those pertaining to this particular 
project on fibrosis of the subepithelial area.  
1. Animals 
Eleven horses belonging to the research herd of the University of Montreal’s 
“Laboratoire de biologie cellulaire et moléculaire respiratoire” were used for this project. 
Six individuals were affected with heaves while the other five were healthy controls. The 
mean weight for all the horses was 486 ± 50.5 kg (445-555 kg). The median age for the 
controls and heaves-affected horses were, respectfully, 15.5 ± 0.8 yrs (11-22 yrs) and 16.8 
± 0.9 yrs (15-19 yrs). Repartition by sex was as follows: the five controls and four heaves-
affected horses were mares, while the two others were geldings. Repartition by breed was 
as follows: five horses were Standardbreds, two were Quarter horses, one was an Arabian 
cross, and all others were mixed-breed. Horses affected with heaves had a history of 
chronic respiratory disease and were intermittently symptomatic for a minimum of three 
years prior to the study. Respiratory function test measurements were abnormal and 
bronchoalveolar lavage (BAL) fluid cytology revealed airway neutrophilia (›25%) in the 
diseased horses. Control horses had a history free of respiratory disease.  All horses 
admitted to the project were vaccinated and dewormed on a regular basis. Prior to the start 
of the study, the subjects were trained to stand in stocks quietly and tolerate masks covering 
their noses and placement of naso-oesophageal catheters and balloons. 
2. Clinical examination and respiratory scores 
During the experimental phase of the project, horses were assessed daily for appetite, 
manure production and general comfort. A brief clinical exam was performed every 
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morning, and the following parameters were recorded: mucous membrane color and 
moisture, temperature, pulse and respiratory rate. Respiratory difficulty was evaluated by a 
clinical score based on a total score of 8 points, performed twice daily. The total score 
comprises two components: nasal flaring (1-4) and abdominal effort on respiration (1-4). 
The use of this clinical score has been validated in the literature (Robinson, et al., 2000). 
Abdominal expiratory effort Score 
Clinically normal 1 
Slight abdominal movement 2 
Moderate abdominal movement 3 
Severe and substantial abdominal 
movement 
4 
 
Nostril Flaring Score 
Clinically normal 1 
Slight and infrequent nostril flaring 2 
Moderate nostril flaring 3 
Severe and continuous flaring for 
each breath 
4 
 
Total clinical score Score 
Clinically normal 2 
Mild respiratory signs 3 or 4 
Moderate respiratory signs 5 or 6 
Severe respiratory signs 7 or 8 
 
Table 1  Description of the respiratory clinical scores performed on the subject horses 
during the experimental phase of the project 
3. Bronchoalveolar lavage  
Bronchoalveolar lavage (BAL) was performed on sedated horses standing in stocks by 
a method previously described (Leclere, et al., 2010). A 2.5 meter bronchoscope (Olympus 
Medical Systems corp., Tokyo, Japan) was inserted through the medial nasal meatus to 
access the upper respiratory tract.  The bronchoscope was oriented in the main bronchi 
where two, 250-mL boluses of isotonic saline were instilled. BAL fluid was then collected 
in siliconized glass vessels, and placed on ice. Following filtration through sterile gauze, 
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the BAL fluid was centrifuged (1500 rpm at 5 °C for 5 minutes) and cell pellets were re-
suspended (RMPI 1640 culture medium). Analysis of fluid was performed within one hour 
of sampling. A hemocytometer was used to establish total cell counts on fresh lavage 
samples.  Differential cell counts obtained with a cytospin slide were stained with Wright-
giemsa and Toluidine blue.  A minimum of 400 cells per specimen were counted under oil-
immersion microscopy. 
 
4. Lung function measurements 
Respiratory mechanic function tests were performed on unsedated horses standing in 
stocks. A heated pneumotachograph4 was used to obtain flow rates of inspired and expired 
air. The pneumotachograph was linked to a differential pressure transducer5. Electronic 
integration of the flow signal as a function of time yields the tidal volume (Vт). Before 
recording measures, system calibration was performed by submitting the 
pneumotachograph to known flow rates.  Difference in transpulmonary pressure (PL) is 
calculated using a differential pressure transducer6
  Once equipment preparation was set, ninety second breathing sequences were recorded. If 
the horse moved or swallowed during the sequence, it was repeated to record at least ten 
good breaths.  Amplified transducer signals cross a digital converter and are sent to a 
 which allows esophageal pressure to be 
subtracted from atmospheric pressure. Esophageal pressure was measured by placing a tied 
balloon around a naso-esophageal polyethylene catheter which was then placed in the distal 
third of the esophagus. Before measures were taken, the balloon was distended with air to 
check for leaks. The placement of the esophageal balloon was adapted for each horse in 
order to avoid cardiac interference and to obtain the greatest possible variation of pressure 
between inspiration and expiration. The most favorable position was recorded and used for 
further tests. A water manometer was used for pressure transducer calibration prior to 
measurements.  
                                                 
4 Fleisch No. 4, Oern Medical, Richmond, Virginia, USA 
5 Model 143PC03D, Micro switch, Honeywell, Scarborough, Ontario, Canada 
6 Model HCXPM005D6V, Sensor Technics, Newport News, Virginia, USA 
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computer system with data acquisition software7
PL = (EL x V) + (RL x ) + K  
 to obtain measurements. Signal frequency 
was 120 Hz during measurement recordings. Pulmonary resistance (RL) and elastance (EL) 
values were deduced from applying the following formula: 
    : Flow rate 
V : Volume 
K : End expiration transpulmonary pressure 
The determination coefficient of the above formula was calculated for each respiration.  
5. Thoracoscopic guided peripheral lung biopsy procedure  
Two thoracoscopic guided lung biopsy procedures were performed on each horse, with 
a thirty day interval, using a method previously described (Relave, et al., 2008). In brief, 
horses were secured in standing stocks and premedicated with intravenous detomidine HCl 
(6µg/Kg) and butorphanol (0.02mg/kg).  Detomidine was administered throughout the 
procedure at a continuous infusion rate of 0.8 mg/kg/min for the first fifteen minutes and 
decreased by half every fifteen minutes from then on. On each procedure day, a 
thoracoscopy was performed on a control and heaves-affected horse. Biopsies were 
obtained from the same hemithorax, selected at random, on the given day. The other 
hemithorax was used for the second thoracoscopy thirty days later. Aseptical surgical 
preparation and local anesthetic infiltration (2% lidocaine) were completed prior to the 
thoracoscopic procedure using a pre-tied ligating loop. Post-operatively, intramuscular 
procaine penicillin (22,000U/kg) and intravenous phenylbutazone (2.2mg/kg) were 
administered to the horses; this was continued twice a day for two additional days. Horses 
were visually monitored for twenty four hours in their stalls before being returned to the 
pasture. Clinical exams were then performed as follows: at two and twelve hours post 
surgery, BID for the next two days, and SID for the following five days.  Radiographic 
                                                 
7 Anadat and Labdat 5.1, RHT-Infodat, Montreal, Qc, Canada 
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examination of the thorax was also performed pre and post operatively to assess for the 
presence of pneumothorax or other pulmonary complications. 
6. Experimental protocol 
For three months before the study began, the horses were kept on pasture in an antigen 
poor environment to induce disease remission (antigen withdrawal period). In addition to 
access to grazing pasture, the subjects were fed a pelleted hay ration and sweet feed twice a 
day. During this time, the heaves-affected horses were in clinical remission and exhibited 
no signs of respiratory disease.  Lung function tests and bronchoalveolar lavage were 
performed near the end of the three month antigen withdrawal period; these were followed, 
seven to ten days later, by the thoracoscopic guided lung biopsy procedure.  
After recovery from the surgical procedure, a 30-day antigenic challenge was started.  
During this period, horses were housed in a dusty stable environment. They were bedded 
on straw, fed timothy hay, and received sweet feed twice a day. In addition, dusty and 
mouldy hay was shaken in front of the horses’ faces for three minutes every morning.  
Heaves-affected horses developed signs of airway obstruction that were manifested by 
flaring of the nostrils and an abdominal component to respiration. Controls remained 
normal and showed no signs of respiratory disease during this period. Lung function tests, 
bronchoalveolar lavage and thoracoscopic biopsy procedures were repeated (seven to ten 
days apart) at the end of the thirty day antigenic challenge (T30). At T30, all heaves-
affected horses had a clinical respiratory score ≥ 6. Histomorphometric assessment of 
subepithelial area collagen deposition of the T0 and T30 peripheral lung biopsies was then 
performed at an ulterior date. 
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Figure 8  Schematic representation of the experimental protocol 
7. Picrosirius-red staining procedure 
Peripheral lung tissue biopsies were soaked in 10% neutral-buffered formalin for 24 
hours before being embedded in paraffin and mounted in blocks according to standard 
procedures.  Using a microtome, they were then cut to a five µm thickness and mounted on 
standard microscope slides. Slides were then incubated at 37°C overnight to allow proper 
tissue adhesion to the slide. The picrosirius-red coloration was performed to specifically 
stain collagen fibers (Sweat, et al., 1964). A pre-digestion step with 0.5% papain solution 
was performed in order to remove proteoglycans and permit the stain to better penetrate 
collagen fibers, following the protocol used by Lecocq et al. (2008) (Annexe A).  
8. Histological examination 
Assessment of all histological sections was done by the same observer, who was 
blinded as to which group the horses belonged to and the time period being evaluated. 
Picrosirius-red stained lung tissue sections were evaluated under brightfield microscopy, 
with the use of a Leica DM4000B polarized light microscope (PLM). All lung tissue on the 
slide was carefully screened under the microscope field at 5X objective magnification for 
0 30 days
√
√
√
Antigen challenge (mouldy hay and straw)
Lung function tests
(PL, RL, EL)
√
Histomorphometry
Peripheral lung biopsies
(Thoracoscopic guidance)
√
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√ √
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recognizable peripheral airways. Once located, the selected airway was centered and the 
microscope magnification strength was adjusted (10X or 20X), depending on the airway 
size. The airway was positioned to take up most of the microscope field.  If the airways 
responded to the criteria described below, they were digitalized with a Leica DFC320 video 
camera, mounted on the microscope.  
 
Stain coloration Smooth muscle Internal 
perimeter of 
epithelium 
Airway size Airway angle 
Picrosirius-red 
stain had to be 
successful in 
that collagen 
fibers appeared 
red and contrast 
was apparent 
with other 
tissue elements 
Minimum of 
50% of airway 
smooth muscle 
had to be 
present around 
subepithelial 
layer 
Intact enough 
to allow 
perimeter 
measurement 
using tracing 
tool 
Airways that 
could be 
digitalized with 
a 10X or 20X 
objective  
magnification 
strength  
Airways 
offering a close 
to 
perpendicular 
cross-section  
 
Table 2  Inclusion criteria for digitized airways used for morphometric analysis 
 
To exploit collagen birefringence properties, peripheral airways were further analyzed 
under polarized light. Prior to digitalizing images, extinction on a black background was 
performed with the two cross polarizer filters (polarizer and analyzer) equipped with the 
microscope. These two filters are placed at 90 degrees from each other. The polarizer 
polarizes light as it traverses the tissue, while the analyzer limits other interfering light 
sources.  A digitized image of a stage micrometer8
                                                 
8 Fisher Micromaster Microscope Stage Micrometers; 2mm with 0.01mm division 
 at 10X and 20X magnification was also 
taken in order to calibrate image size when using image analysis software. 
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A.                                                   B. 
Figure 9  A. Normal peripheral equine airway stained with picrosirius-red. The 
subepithelial collagen area is stained red and is discernable from the surrounding smooth 
muscle layer. B. Same airway under polarized light. 
9. Image analysis  
Digitized airway images were transferred to the computer software program MBF Image 
J® (National Institutes Health)9. The threshold colour Plugin10
James, Pare, & 
Hogg, 1988
 function was added to the 
software to allow for more specific subepithelial area collagen selection.  A known distance 
on the stage micrometer was recorded (2 mm) for the given magnification and set into the 
software for automated calibration in µm units. Using a designed protocol (Annexe B), 
subepithelial collagen (stained red) was subtracted from the rest of the image and its area 
(µm²) was measured and recorded.  The internal perimeter of the airway epithelium (µm) 
was also measured using the software tracing tool. The collagen area in the subepithelial 
layer was then corrected for airway size using a standard correction factor (
). 
 
Corrected collagen = subepithelial collagen area (µm²) /internal perimeter (µm) ²  
The internal perimeter of the airway has been demonstrated as a reliable marker of airway 
size and stays constant regardless of changes in degree of smooth muscle shortening or 
relaxation (James, et al., 1988); it was thus used to adjust for airway size.  The same 
background correction factor was also applied to all images to facilitate subepithelial area 
and smooth muscle differentiation. 
                                                 
9 Image J®, McMaster Biophotonics Facility Image J for Microscopy version 12.41, National Health Institute 
10 Threshold_colour function Plugin,, designed by G. Landini 
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      A.                                                            B. 
 
 
 
 
 
 
 
 
       C.                                                            D. 
 
Figure 10  Steps for image analysis of picrosirius-red stained peripheral airways. A. 
Picrosirius-red stained airway. B. Background correction factor applied and subepithelial 
area collagen selected with a black colored tracing tool. C. Subepithelial area collagen is 
extracted from the image and area can be measured. D. Internal airway epithelium 
perimeter is hand traced with a black colored tracing tool and measured. 
10. Polarized light microscopy assessment 
All digitized picrosirius-red stained images under polarized light were printed on 
standard paper. They were visually sorted by an observer, who was blinded as to which 
group of horses the airways belonged to. Airways were subjectively assessed for 
differences pertaining to collagen fiber spatial distribution or regional changes in the 
polarized colors. Quantification of collagen fibers by color assortment was attempted using 
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the threshold color Plugin with MBF image J®. However, due to large varieties of shades 
in the different polarization colors, proportioning their distribution in the subepithelial layer 
of the airway was not possible. Subjective evaluation of the collagen fibers in the muscle 
layer was more feasible, as its delimitation from the other structures was easier to establish 
because of its dark appearance under polarized light. Images were divided in two categories 
based on presence or absence of collagen fibers in the smooth muscle layer. Presence of 
collagen fibers meant that the airway smooth muscle, which would normally appear black 
under polarized light (no birefringence properties), was interspersed with collagen fibers 
(bright green, yellow or orange). Absence of collagen fibers meant that the airway smooth 
muscle remained black or had very small amounts of collagen fibers interspersed within it. 
  
A.           B.  
Figure 11  Picrosirius-red stained airways under polarized light were divided into two 
categories based on presence or absence of collagen fibers in the airway smooth muscle. A. 
The ASM is encircled in red. The presence of green birefringent collagen fibers can be 
observed. B. The ASM is encircled in red. A dark appearance and absence of brightly 
colored collagen fibers is noted. 
 
11. Statistical analysis 
A two way ANOVA was used for the statistical analysis of the respiratory function 
parameters, BAL total cell counts (%) and neutrophil cell count (%). Data were considered 
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significant if p<0.05.  Statistical analysis was performed with Prism 5 (GraphPad software, 
La Jolla, Ca, USA) analysis software. 
A repeated measures ANOVA was used for the statistical analysis of the airways’ 
collagen content (Collagen area/ perimeter²).  Mean collagen content was calculated for 
every horse with time (within-subject) and groups (between-subject) main effects.  Data 
were considered significant if p<0.1. Statistical analysis was performed with the Super 
ANOVA (Abacus Concepts, Berkeley, Ca, USA) analysis software. 
A two-sided Fisher exact test was used for analysis of the qualitatively assessed 
collagen content in the airway smooth muscle of picrosirius-red stained airways under 
polarized light in heaves-affected and control horses. Results were considered significant if 
p<0.05. Statistical analysis was performed with Prism 5 (GraphPad software, La Jolla, Ca, 
USA) analysis software. 
Associations between measures of pulmonary function (RL, EL and PL), BAL total cell 
counts (%), neutrophil cell count (%) and mean collagen content were measured by a least 
squares linear regression and the coefficient of determination R². A p value inferior to 0.1 
was considered significant. Prism 5 (GraphPad software, La Jolla, Ca, USA) analysis 
software was used. 
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RESULTS 
1. Picrosirius-red stained equine peripheral airways 
The picrosirius-red histological dye was successful in staining peripheral equine 
airways obtained by the thoracoscopic guided lung biopsy procedure. Subepithelial area 
collagen stained red, could be extracted from the image and its area measured.  For the 
controls (n=5) and heaves-affected horses (n=6), respectively, fifty six (range 6-15 airways 
per horse) and fifty eight (range 4-15 airways per horse) peripheral airways were assessed 
with histomorphometric techniques.  
Horse Group Number of sampled 
airways at T0 
Number of sampled 
airways at T30 
1 Control 4 2 
2 Control 9 6 
3 Control 7 5 
4 Control 7 7 
5 Control 6 3 
6 Heaves 10 5 
7 Heaves 7 7 
8 Heaves 3 1 
9 Heaves 5 7 
10 Heaves 5 4 
11 Heaves 2 2 
 
Table 3  Peripheral equine airway repartition between heaves-affected horses and controls, 
divided between T0 (antigen withdrawal) and T30 (antigen exposure) assessment periods. 
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2. Descriptive observations of picrosirius-red stained airways under brightfield        
microscopy 
     Subepithelial area collagen distribution was very heterogeneous among the digitized 
picrosirius-red stained airways in both groups of horses. Some airways had a very dense 
collagen fiber network, taking up most of the subepithelial area, while others had an 
uncondensed collagen network, with large areas of empty space between fibers, likely 
attributed to a processing artifact. Most airways’ circumferential distribution of collagen 
fibers around the epithelium was symmetrical. However, a minority of airways had 
markedly uneven circumferential collagen distribution in the airway subepithelial area. 
Airway smooth muscle followed this same tendency.  Important differences in collagen 
distribution could be observed within the airways of a given horse. A relatively constant 
observation was that airways possessing a denser and thicker subepithelial collagen area 
generally also possessed substantial airway smooth muscle surrounding the latter, and this 
independent of the degree of airway contraction.  Most collagen fibers in the subepithelial 
area were heterogeneously dispersed and no specific pattern or fiber orientation was 
visualized. However, two airways had collagen fibers that appeared to be oriented 
perpendicular to smooth muscle fibers around the whole airway. The presence of collagen 
fibers in the airway smooth muscle was a feature of multiple airways. 
Airway epithelium was generally well defined, intact and its internal perimeter easy to 
delimitate from the airway lumen. Occasional airways had a partly torn epithelium, which 
likely arose during tissue processing, but generally didn’t affect the internal perimeter 
measurements. The degree of airway contraction varied greatly in all airways, independent 
of the group or time period evaluated.  
Although not a focus of this study, mucus could be visualized in the airway lumen in a 
minority of horses.  
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3. Respiratory scores of heaves-affected horses and controls before and after a thirty day 
antigenic challenge with mouldy hay and straw 
At T0, all five control horses had a total respiratory score of 2, which corresponds to 
clinical normalcy. In the heaves-affected horses, three individuals had a total respiratory 
score of 2. The remaining individuals of this group had a total respiratory score of 3, 
corresponding to mild respiratory symptoms. 
 At T30, the total respiratory scores of all the horses in the control group remained at 2. 
In the diseased horses, three individuals had a total respiratory score of 6, corresponding to 
moderate respiratory signs. The remaining individuals of this group had a total respiratory 
score of 8, corresponding to severe respiratory signs. All the heaves-affected horses showed 
clinical signs of airway obstruction, evidenced by marked increase in abdominal effort on 
respiration and flaring of the nostrils.  
4. Respiratory mechanics of heaves-affected horses and controls before and after a thirty 
day antigenic challenge with mouldy hay and straw 
After three months of low antigen exposure (T0), there is no difference in pulmonary 
function parameters between controls and heaves-affected horses. After thirty days of 
antigenic challenge (T30), only heaves-affected horses developed significant airway 
obstruction (p<0.01)11
 
.  
                                                 
11 Results obtained from ˝Leclere, M., A. Lavoie-Lamoureux, et al. (2010). "Effect of Antigen Exposure on 
Airway Smooth Muscle Remodeling in an Equine Model of Chronic Asthma." Am J Respir Cell Mol Biol. In 
Press.ʺ 
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Figure 12   Pulmonary elastance before (T0) and after (T30) a thirty day antigenic 
challenge in heaves-affected horses and controls (Mean ±SEM) *p<0.01: Different from T0 
within the same group and controls at the same time point. 
 
Figure 13  Pulmonary resistance before (T0) and after (T30) a thirty day antigenic 
challenge in heaves-affected horses and controls (Mean ±SEM. *p<0.01: Different from T0 
within the same group and controls at the same time point. 
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Figure 14  Maximal changes in transpulmonary pressure before (T0) and after (T30) a 
thirty day antigenic challenge in heaves-affected horses and controls (Mean ±SEM). 
*p<0.01: Different from T0 within the same group and controls at the same time point. 
 
After three months of antigen exposure (T30), there was a significant increase in BAL 
neutrophil cell count (%) in heaves-affected horses and controls (p<0.01). No difference 
between groups could be appreciated. There were no significant group or time effects on 
the total cell counts (%). 
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Figure 15  BAL neutrophil cell count (%) before (T0) and after (T30) a thirty day antigenic 
challenge in heaves-affected horses and controls (Mean±SEM). * p<0.01: Different from 
T0 within the same group. 
 
Figure 16  BAL total cell counts (%) before (T0) and after (T30) a thirty day antigenic 
challenge in heaves-affected horses and controls (Mean±SEM). 
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5. Subepithelial area collagen content in the airways of heaves-affected horses in 
comparison with controls 
   In comparison with controls, horses with heaves have an increased collagen content in 
the airway subepithelial area (p=0.0586). Collagen content is denoted as subepithelial area 
corrected for airway size (collagen area / Perimeter²). However, no time main effects or 
time or group-time interaction (p›0.1) were observed. The thirty day antigen challenge 
failed to alter subepithelial area collagen content in airways of control or heaves-affected 
horses. (c.f Figure 17 and 18). 
 
 
Figure 17  Peripheral airway subepithelial area collagen content (mean per horse) before 
(T0) and after (T30) a thirty day antigenic challenge in controls and heaves-affected horses 
(mean±SEM) * p<0.1: Different between groups. 
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Figure 18  Peripheral airway subepithelial area collagen content (mean per horse) divided 
by controls and heaves-affected horses. T0 and T30 peripheral airway subepithelial area 
collagen mean values per horse are shown.  
6. Airway distribution of heaves-affected horses and controls as a function of time 
Subepithelial area collagen content in the airways of controls and heaves-affected 
horses before (T0) and after (T30) a thirty day antigenic challenge are distributed as a 
function of airway size, represented by the epithelial membrane internal perimeter (µm). 
The increase in subepithelial area collagen content in heaves in comparison with controls is 
especially present in airways of smaller diameter. The difference between both groups 
appears to normalize as airways increase in size (›1725µm Pi) (c.f figure 19). 
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Figure 19  Peripheral airway subepithelial area collagen content (T0 and T30) as a 
function of airway size (epithelium membrane internal perimeter (µm)) 
 
When peripheral airways before (T0) and after (T30) a thirty day antigenic challenge 
are shown for every subject, interindividual variation in collagen content is high within the 
peripheral airways of a given horse. Individual variability is present in both controls and 
heaves-affected horses (c.f figure 20-21). 
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Figure 20  T0 and T30 individual peripheral airway subepithelial area collagen content for 
each control horse (horses’ # 1-5). 
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Figure 21  T0 and T30 individual peripheral airway subepithelial area collagen content for 
each heaves-affected horse (horses’ # 6-11).  
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7. Peripheral airway subepithelial area collagen content as a function of pulmonary 
resistance, elastance and maximal changes in transpulmonary pressure 
   Peripheral airway subepithelial area collagen content was positively associated with 
maximal changes in transpulmonary pressure (PL) at T0 in heaves-affected horses, p=0.003, 
r²=0.91. A similar tendency was observed with pulmonary resistance (RL), p=0.067, r²=0.61.  
No association was observed with pulmonary elastance (EL) at T0 in heaves affected-horses, 
p›0.1.  No association was present between peripheral airway subepithelial area collagen content 
and pulmonary resistance, elastance or maximal changes in transpulmonary pressure in control 
horses at T0 or at T30, p›0.1.    
 
 
 
Figure 22  Maximal changes in transpulmonary pressure as a function of peripheral airway 
subepithelial area collagen content of horses with heaves and controls after 3 months of 
antigen withdrawal (T0) and after 30 days of antigen exposure (T30).  
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Figure 23  Pulmonary resistance as a function of peripheral airway subepithelial area 
collagen content of horses with heaves and controls after 3 months of antigen withdrawal 
(T0) and after 30 days of antigen exposure (T30).  
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Figure 24  Pulmonary elastance as a function of peripheral airway subepithelial area 
collagen content of horses with heaves and controls after 3 months of antigen withdrawal 
(T0) and after 30 days of antigen exposure (T30). 
 
8. Peripheral airway subepithelial area collagen content as a function of BAL total cell 
counts (%) and neutrophil cell count (%) 
No association was observed between peripheral airway subepithelial area collagen 
content and BAL total cell counts (%) or neutrophil cell count (%) in either group, at both 
T0 and T30. 
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9. Descriptive observations of picrosirius-red stained subepithelial area collagen under 
polarized light  
No qualitative changes in polarized colors (bright red, yellow, orange, green) could be 
visually appreciated in the subepithelial area of the airway. Furthermore, this region was 
difficult to delimitate. No quantitative assessment could be performed due to difficulty in 
separating polarized colors using the Image J® program threshold color tool. 
10. Airway smooth muscle (ASM) qualitative assessment of collagen fiber presence under 
polarized light 
            Airways were divided into two categories: 1) presence of collagen fibers in the ASM 
and 2) absence or very little presence of collagen fibers in the ASM. Of the fifty airways 
which had similar polarization color results and were sorted by a blinded observer; twenty-
three heaves-affected airways and twelve control airways were sorted as having presence of 
collagen fibers in the airway smooth muscle; fifteen controls and five heaves-affected horses 
were sorted as having no or very little collagen in the airway smooth muscle layer. The two-
sided Fisher exact test revealed that heaves-affected horses had statistically more airways 
with presence of collagen fibers in the ASM, than control horses (p=0.0052). Most of the 
collagen fibers observed in the ASM were of the green polarization color (c.f figure 25). 
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Figure 25  Presence or absence of collagen fibers in the airway smooth muscle of horses 
with heaves and controls * p<0.01: Different for Presence of collagen in ASM between 
groups. 
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DISCUSSION 
1. Subepithelial area collagen content in the airways of heaves-affected horses and 
controls 
 
In light of these results, fibrosis of the subepithelial area appears to be another 
feature of airway remodelling occurring in heaves, likely contributing to disease 
pathophysiology. Our results are difficult to correlate to prior studies on lung fibrosis in 
heaves (Kaup, et al., 1990; Thurlbeck & Lowell, 1964; Winder & von Fellenberg, 1988), 
since the qualitative changes described in the latter pathology reports refer mostly to the 
interalveolar and peribronchial region of the lung. However, our results corroborate and 
extend these reports by showing that collagen content also increases in the subepithelial 
area of small peripheral airways in diseased animals in comparison to controls.    
 
While the difference in subepithelial collagen content between the two groups of 
subject horses reached significance (p=0.0586), there are several possible explanations that 
may account for the lack of greater significance. The relatively low number of sampled 
diseased individuals (n=6) combined with the observed high interindividual variability in 
collagen content in the subepithelial region, are probable contributing factors. The 
arithmetic mean ( ) of all the airways’ collagen content in the subepithelial area was used 
to compare remodelling changes between groups. However, the extensive dispersion of 
data points and presence of outliers observed within the airways of a same horse could 
skew the mean value, and thus inaccurately represent airway collagen deposition for a 
given animal. Additionally, digitized picrosirius-red stained airways for which the smooth 
muscle layer didn’t completely encircle the airway required subepithelial area collagen to 
be arbitrarily delimited from surrounding connective tissue. Such estimations may account 
for some of the variability observed.  
 
A recent study used an immunolabeling method to identify collagen type I and type 
III fibers in the lamina propria and adventia of bronchioles in heaves-affected and control 
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horses, and to assess if fibrosis was present in diseased animals (Furness, et al., 2010). A 
semi-quantitative score was used to evaluate differences in collagen content between the 
two groups of horses; however no significant difference was appreciated. While at first 
sight these results appear to contradict our findings, limitations of the latter study could 
account for our diverging conclusions.  
First, the number of diseased horses sampled (n=4) and tissue sections obtained per 
horse (n=8) were small.  Our study attests that interindividual variation is high in sampled 
individuals, making a type II statistical error plausible. Remodelling changes may have 
occurred at different stages in a given horse at the time lung samples were obtained. Since 
heaves is a naturally occurring chronic respiratory condition, the degree of ECM turnover 
may manifest itself only at certain periods of time in disease progression, and thus could 
require a greater number of individuals to properly assess remodelling changes. Yet, 
heaves-affected horses were aged between sixteen and twenty eight years at the time of 
death and three out of four individuals had a long term history of heaves, suggesting that 
the disease was advanced enough that a change in collagen deposition would have been 
present, making this hypothesis less likely.  
In addition, airway size was not taken into consideration when assessing collagen 
content in the airways of subjects in the Furness et al. (2010) study.  Airways of subject 
horses were not infused at a constant rate following lung removal from the cadavers, 
making the application of a correction factor for airway size pivotal. Our study showed that 
fibrosis of the subepithelial area was more markedly increased in smaller airways 
(>175µm), further justifying the use of a correction factor. The epithelial membrane 
internal perimeter (Pi) applied as a correction factor for airway size has been shown to be 
independent of lung volume or the degree of airway dilation or contraction due to 
bronchoconstriciton (James, et al., 1988), and should have been used in the Furness et al. 
(2010) study. Pi is believed to be a consistent parameter in the airway because of its 
attachment to the underlying inextensible basement membrane.  
Furthermore, while the collagens evaluated with the immunolabeling method (Col I 
and III), are the most abundant in the lungs of mammalian species (Last & Reiser, 1984), 
other collagen types are known to be present in the lung and were not evaluated.  In human 
asthmatics, collagen types I and III are known to be increased in the subepithelial region of 
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the airway.  However, collagen type V is also present in increased proportions in this 
region of the airway as well as in the submucosa (Bergeron, Al-Ramli, & Hamid, 2009; 
Elias, 2000; Hoshino, et al., 1998; Wilson & Li, 1997). A method to characterize its 
presence in normal or heaves-affected individuals has never been investigated, and its 
increased presence in heaves-affected horses could partly account for the studies’ diverging 
results.  
Additionally, collagen types were compared individually between the two groups of 
horses. It is possible that their combined assessment would yield an appreciable difference 
in the airways of diseased versus controls airways.  
The authors further submitted the hypothesis that albeit the control horses (n=10) 
didn’t have a history of exercise induced pulmonary hemorrhage (EIPH), the condition is 
known to cause collagen remodelling in the interlobular veins and in the pleura and 
interlobular septa of the lung (Williams, et al., 2008). It is conceivable that if the control 
horses had suffered a prior episode of this condition, it could confound the difference in 
collagen content between the two groups of horses. Moreover, seven of the ten controls in 
the study were either Thoroughbreds or Standardbreds, and both these breeds are at risk for 
EIPH (Williams, et al., 2008). 
Research in progress in our laboratory is attempting to quantify the presence of 
collagens type I and III in the lungs of heaves-affected horses and healthy controls, using 
immunohistochemical techniques. The information provided by these results will likely 
elucidate the present unanswered questions. 
 
2. Etiology of airway fibrosis in heaves 
 
 Airway inflammation and hyperresponsiveness are believed to be involved in the 
mechanisms leading to fibrosis in human asthma, although the exact pathways have yet to 
be explained. As previously discussed, we suspect that similar mechanisms occur in 
heaves, because of shared aspects of airway inflammation and hyperresponsiveness with 
asthma. 
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 Inflammation of allergic origin in asthma is one of the proposed etiologies of 
airway remodelling.  The Th2 and Th17 type cytokine profiles present in asthmatics results 
in the activation of many mediators known to have fibrogenic properties. TGF-ß1, a 
fibrogenic mediator discussed earlier, has been associated with the presence of 
subepithelial fibrosis in human asthmatics and in murine models.  A study in human 
asthmatics correlated the severity of subepithelial fibrosis with the expression of TGF-ß1  
(Minshall, et al., 1997).  Similarly, investigators showed that the presence of subepithelial 
fibrosis in a mouse model of asthma could be correlated with increased levels of TGF-ß1 in 
the bronchoalveolar lavage (BAL) fluid of the subjects (Tanaka, et al., 2001). However, 
another report in human asthmatics failed to positively correlate type III collagen 
deposition with TGF-ß1 expression, suggesting other factors are involved in remodelling 
changes (Tomkowicz, et al., 2008).  
A study by Jenkins et al. (2003) reported various remodelling changes in airway 
biopsies obtained from children with severe asthma. In five out of six subjects, little or no 
evidence of airway inflammation was present, again suggesting other mechanisms are 
responsible for the remodelling observed. However, the authors could not exclude the 
possibility that airway inflammation was present in the individuals, albeit more distally 
than the sampled area. 
A problem involving the epithelial repair process is another proposed etiology for 
the remodelling changes observed in asthmatics. Close interactions between the epithelium 
and subepithelial layer, defined as the epithelial-mesenchymal trophic unit (EMTU), are 
important in lung development, and believed to be impaired in asthma (Holgate, et al., 
2004). Chronic airway inflammation causes repeated insults to the epithelium, and the 
latter’s inability to properly recover could lead to ongoing activation of the EMTU and 
consequent remodelling of the airway. It is suspected that the repair process of the damaged 
epithelium is abnormal in asthmatics, leading to activation of secondary repair mechanisms 
and subsequent deposition of collagen in the airway. Activated epithelial cells have the 
ability to secrete pro-fibrotic mediators, such as TGF-ß2 and fibroblast growth factor-2, 
which promote fibroblastic cells to produce ECM proteins. Minshall et al. (2000) showed 
that an increase in IL-11 expression, a cytokine secreted by subepithelial cells, could be 
correlated to the deposition of type I and III collagen in a localized airway region. 
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Swartz et al. (2001)  used an in vitro model of cultured human airway epithelial and 
fibroblast cells to study the effects of mechanical stress on airway remodelling. Epithelial 
cells submitted to mechanical stress resulted in an increase of collagen type III and V 
production by the unstressed fibroblast cells. The degree of remodelling was correlated to 
the magnitude of stress placed on the epithelial cells (Swartz, et al., 2001). These results 
suggest that independent of airway inflammation, mechanical forces acting on the airway 
during episodes of airway hyperresponsiveness may modulate some of the airway wall 
remodelling occurring in heaves. 
All of the proposed etiologies could be contributing to the development of fibrosis 
in heaves and need further exploration. 
 
3. Airway fibrosis and lung function 
 
The role of airway fibrosis in asthma or heaves in relation to lung function is not 
completely understood. While some have suggested that fibrosis serves as a protective 
response to airway disease, others have proposed mechanisms in which airway fibrosis is 
detrimental to lung function and contributes to airway narrowing. 
 A mechanism by which fibrosis of the subepithelial area in heaves could protect 
against airway hyperresponsiveness is through stiffening of the airway wall. A thickened 
airway would theoretically result in decreased distensibility, also known as compliance, 
which in areas of limited air flow (bronchoconstriction) could assist in preserving peak 
expiratory flow (PEF), even if the airway lumen was reduced in size (McParland, 
Macklem, & Pare, 2003). Such a hypothesis was tested in a study using a rat model of 
asthma induced with aerosolized ovalbumin (OVA).  Increased collagen and fibronectin 
deposition was present in the airways of asthmatic rats in comparison to controls after the 
twelve week challenge. Interestingly, airway response to carbachol, a cholinergic agonist, 
was similar in both groups of rats at the end of the trial, suggesting airway remodelling was 
protecting against hyperresponsiveness (Palmans, Kips, & Pauwels, 2000).  
 Increased collagen deposition around smooth muscle cells has also been proposed to 
limit airway smooth muscle shortening and airway narrowing by altering the "elastic 
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afterload". "Elastic afterload" develops as narrowing compresses tissue structures, and 
increase in collagen content could potentially intensify this phenomenon (McParland, et al., 
2003).  
 Mechanisms by which airway fibrosis leads to a detrimental impact on lung 
function have also been advanced. The principle by which an increase in airway wall 
thickness exerts a magnifying effect on smooth muscle shortening was initially proposed by 
in vitro mathematical models (Moreno, Hogg, & Pare, 1986). A post-mortem study on the 
airways of asthmatic and non-asthmatic individuals further corroborated the model, 
determining that asthmatic airways, in comparison to controls, had a greater airway wall 
thickness, and thus required a lesser degree of smooth muscle shortening to completely 
occlude the airway (James, Pare, & Hogg, 1989).   
Another potential negative impact of increased remodelling in the airway wall is 
through the loss of parallel elastance of connective tissue to the airway smooth muscle 
(McParland, et al., 2003). Products of airway inflammation could hypothetically result in 
proteolysis and subsequent architectural alterations of collagen fibers and other ECM 
proteins.  An earlier in vitro study on human bronchial tissue by Bramley et al. (1995) 
supports this theory. The group demonstrated that collagenases, enzymes of collagen 
degradation, could alter bronchial tissue function and lead to loss in tissue elastance and 
intensify smooth muscle shortening (Bramley, Roberts, & Schellenberg, 1995).   
 
The relationship between subepithelial fibrosis and lung function is further 
complicated by the presence of conflicting information on the subject. A study by Shiba et 
al. (2002) correlated subepithelial thickening in mild asthmatics to duration of disease, 
airflow limitation and airway hyperresponsiveness. Others have found similar parallels 
between subepithelial fibrosis and lung function deficits (Chetta, et al., 1997) or airway 
hyperresponsiveness (Hoshino, et al., 1998), supporting the hypothesis that remodelling can 
impair lung function. Nevertheless, such a correlation is not a universal finding (Brewster, 
et al., 1990; Jenkins, et al., 2003).  
Our results indicate the presence of a positive correlation between subepithelial area 
collagen content in the peripheral airways of heaves-affected horses and the maximal 
changes in transpulmonary pressure (PL) measurements, indicating that airway fibrosis has 
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a detrimental effect on airway function. A similar tendency is present with pulmonary 
resistance (RL). This may explain the higher RL and PL measures in diseased horses while 
in remission (free of clinical symptoms of airway obstruction). These findings suggest that 
fibrosis of the subepithelial area plays a role in passive airway obstruction.   
The positive association between fibrosis of the subepithelial area and RL did not 
reach significance. However, RL is a calculated value derived from a linear regression 
equation, which may possibly not adequately represent the mechanics of the diseased 
equine lung. A greater number of sampled individuals may have allowed significant 
changes to become evident, as observed with PL.   
The lack of association between fibrosis of the subepithelial area and PL or RL in 
the control group suggests that in healthy individuals with normal respiratory patterns, 
airway subepithelial area collagen content does not influence lung function parameters.  
The lack of association between PL and RL with fibrosis of the subepithelial area 
after a thirty day antigenic exposure (T30) could be explained by the predominating 
influence of bronchospasm on lung function in diseased animals. Therefore, the association 
with fibrosis of the subepithelial area is no longer observed. While these results were 
expected, a negative correlation between fibrosis and lung function may have indicated a 
protective effect as discussed above. 
No correlation between fibrosis of the subepithelial area and EL was established. 
These results were surprising since EL is a measure believed to be representative of the 
mechanical elastic properties of peripheral airways (Robinson, et al., 2000), and 
remodelling changes in heaves and asthma are suspected to be mostly contained to the 
smaller peripheral airways.  RL is a better indicator of airflow obstruction occurring in the 
large and small central airways (Robinson, et al., 2000). It is thus possible that our 
population of heaves-affected horses is part of a sub-phenotype of disease, as is seen in 
human asthmatics (Kaczka, Ingenito, Israel, & Lutchen, 1999).  Type A asthmatics are 
known to have increased RL values but EL values similar to that of healthy individuals.  
High RL and EL values are more typical of Type B asthmatics, associated with a more 
severe form of disease. These different pulmonary mechanic patterns exhibited by 
asthmatics are likely due to differences in the viscoelastic properties of lung tissue, 
shunting of the airway wall and severity of airway obstruction (Kaczka, et al., 1999; 
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Kaczka, Ingenito, Suki, & Lutchen, 1997).  No sub-phenotypes of disease have yet been 
described in heaves. 
Also, and as suggested previously, it is possible that the method we used to 
calculate EL may not accurately reflect the elastic properties of the diseased lung.  
 
4. Airway remodelling over time 
Our present findings indicate that fibrosis of the subepithelial area fails to increase 
after a thirty day antigenic challenge with mouldy hay and straw in heaves-affected horses. 
These results were expected, since the development of fibrosis is known to be a chronic 
process evolving over a long period of time, possibly years. It is also generally accepted to 
be poorly reversible. The population of heaves-affected horses used in our study consisted 
of mature animals, having been repeatedly exposed to environmental antigens over several 
years. A thirty day challenge would have been surprisingly rapid for fibrotic changes to 
occur. 
 
No previous equine study has addressed airway remodelling progression in the same 
subjects, in clinical remission or disease exacerbation. In human asthmatics, techniques are 
not available in the clinical setting to track airway remodelling progression in the 
peripheral airways, making the horse a useful model for such an evaluation. Rodent models 
are not naturally-occurring, and poorly represent the course of disease progression in 
humans (Shin, Takeda, & Gelfand, 2009).  Other than cats, horses are the only other 
mammal known to develop spontaneous respiratory disease characterized by airway 
obstruction, when exposed to environmental allergens (Lowell, 1964).   
 
Small rodent models have led to breakthroughs in the understanding of asthma. The 
importance of a Th2-cytokine profile in the pathophysiology of disease evolved from 
studies in mice, for instance (Kumar & Foster, 2002). Advances in genetic manipulation 
have led the development of numerous transgenic mouse models, adapted for the study of 
more specific aspects of disease. Furthermore, small rodent models are cost-effective and 
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relatively easy to breed and manage, when compared to large animal models (Shin, et al., 
2009).  
Nonetheless, there are limitations to the use of small animal models for the study of 
asthma, especially in evaluating chronic changes to airway architecture. Chronic murine 
models of human asthma have been created to mimic certain features of airway 
remodelling, and to address the problem posed by primary or secondary challenge models. 
The latter models develop little airway remodelling and only transitory airway 
inflammation or hyperresponsiveness (Shin, et al., 2009). A research group recently 
compared acute, subacute and chronic murine models of asthma sensitized with OVA 
(Locke, et al., 2007). The chronic challenge model was used to reproduce the long-term 
characteristics of airway remodelling in asthma, such as subepithelial fibrosis and goblet 
cell hyperplasia. However, an increase in airway smooth muscle mass, a dominant feature 
of asthmatic airway wall remodelling, was not observed (Locke, et al., 2007), suggesting 
the chronic model remains incomplete in representing all features of airway remodelling.  It 
has also been shown that some strains of the chronic murine models develop tolerance to 
antigenic exposure and a gradual decrease in airway inflammation and hyperresponsiveness 
can be seen despite continued antigen challenge (Koya, et al., 2006). 
Another drawback of the mouse model for studying remodelling occurring in 
asthma is the marked difference in pulmonary anatomy and physiology compared with 
human subjects. Mice have a different airway branching system and a limited musculature 
of the airway in comparison to people (Shin, et al., 2009).  Humans have a thicker blood-
gas barrier than mice.  These features may contribute to different pulmonary mechanics and 
gas exchange parameters between species (Irvin & Bates, 2003).  
Accurate lung function tests are also more difficult to perform in small subjects.  
The use of non-invasive methods in rodent models such as plethysmography is the center of 
much debate. With this technique, airway function is deduced from a calculated parameter 
known as Penh (enhanced pause), which is derived from alterations in breathing pattern 
(Bates & Irvin, 2003). While plethysmography has the advantage of permitting repeated 
measures in conscious, unrestrained animals, it has been shown to be easily influenced by 
the subject’s metabolism (Irvin & Bates, 2003). While some have demonstrated 
plethysmography as a useful tool in evaluating airway hyperresponsiveness in allergen 
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sensitized and challenged mice (Hamelmann, et al., 1997), it is now generally accepted that 
Penh is a poor representation of lung function (Adler, Cieslewicz, & Irvin, 2004; Petak, 
Habre, Donati, Hantos, & Barazzone-Argiroffo, 2001).   
Invasive methods are more precise, as they offer a direct means of obtaining the 
"Gold standard" pulmonary function parameters; airway resistance and dynamic 
compliance.  The use of tracheostomy with endotracheal intubation has the advantage of 
eliminating the bias presented by interfering upper airway resistance. The main 
disadvantage with the latter technique, however, is the impossibility of obtaining repeated 
measurements (Hoymann, 2006). Other variations of invasive and non-invasive techniques 
exist and can be used to assess pulmonary function in small rodent models, each with 
various advantages and limitations. 
 In equines, the technique described earlier permits lung function measurements 
repeatedly, over time, and in a non-invasive manner. 
5. Thoracoscopic guided lung biopsy procedures for histomorphometric analysis 
 
Ethical considerations preclude the use of thoracoscopic guided lung biopsies for 
the study of airway remodelling in human asthma.  Therefore, evaluation of peripheral 
airway tissue in live subjects is rarely feasible (Balzar, Wenzel, & Chu, 2002), making the 
horse a useful model for evaluating distal airway remodelling in a longitudinal manner. 
Thoracoscopic guided lung biopsy procedures in equines have the advantage of being 
minimally invasive, providing adequate biopsies for histological evaluation and allowing 
repeated sampling over time of peripheral airway tissue in the same subjects (Lugo, et al., 
2002). The two thoracoscopic biopsy procedures performed at a thirty day interval were 
generally well tolerated in the study horses, and recovery was uneventful. Biopsy samples 
were of suitable size for histomorphometric analysis (Relave, et al., 2008).  
Endobronchial biopsies are less appropriate for evaluating remodelling changes in 
the distal airways, as restrictions in equipment length limit sampling to the proximal 
portion of the tracheobronchial tree. Tissue crushing caused by the biopsy forceps can 
cause artifacts which are detrimental to morphometric analysis. Such biopsy specimens 
tend to be smaller in size and only sample a superficial section of the airway wall.  
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Researchers evaluating airway smooth muscle mass in airways of heaves-affected horses 
and controls observed that endobronchial sampling in airways undergoing bronchospasm 
tended to yield more superficial biopsies due to difficulty in properly positioning forceps at 
a thickened carina.  It was speculated that this introduced a bias in relation to the 
percentage of smooth muscle present in the airway (Leclere, et al., 2010).  Endobronchial 
biopsies used to quantify fibrosis of the subepithelial area could potentially yield this same 
bias.  Furthermore, as noted above, fibrosis of the subepithelial area is more prevalent in 
distal airways, making endobronchial biopsies less appropriate for evaluating these 
changes. 
Percutaneous lung biopsies, acquired using a Tru-Cut punch in horses can yield 
appropriate samples for histological analysis in heaves; however the technique requires 
repeated sampling and many complications have been reported (Savage, Traub-Dargatz, & 
Mumford, 1998). 
In human asthmatics, transbronchial biopsies, a half-way method between other 
lung sampling procedures, has proved successful in obtaining good quality samples for 
morphometric analysis and histological differentiation of smaller vs. larger airways (Balzar, 
et al., 2002). Nonetheless, the method is technically challenging and presents risks of 
severe complications such as hemorrhage and pneumothorax (Anders, Johnson, Bush, & 
Matthews, 1988; Bergeron, Tulic, & Hamid, 2007).  There are other drawbacks; the 
majority of tissue sampled contains primarily the alveolar wall as opposed to distal airways 
(Kraft, et al., 1996) and obtaining full airway cross-sections is not possible (Bergeron, et 
al., 2007).  Its usage has never been investigated in equines. 
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CONCLUSION 
Results from our study indicate that fibrosis of the subepithelial area is present in 
the airways of heaves-affected horses as diseased horses have an increased collagen content 
in the subepithelial layer in comparison to controls after three months of low antigenic 
exposure (T0).  Fibrosis may also extend to other components of the airway wall as the 
proportion of green birefringent polarized collagen fibers in the airway smooth muscle 
layer of heaves-affected horses was increased when compared to controls.  Fibrosis of the 
subepithelial area may contribute to the persistent airway obstruction observed in heaves-
affected horses given that it was positively associated to pulmonary resistance (RL) and to 
the maximal changes in transpulmonary pressure (PL) in these animals.  Airway collagen 
remodelling appears to be a gradually evolving process as no significant change was 
observed in collagen content after thirty days of antigenic challenge in either group.  
Morphometric quantification on lung biopsies obtained by a thoracoscopic guided 
procedure was shown as a suitable method to evaluate changes in collagen content in the 
airway of picrosirius-red stained histological sections.   
While our research results contribute valuable information on airway remodelling 
and its relationship to lung function in heaves-affected horses, there are nonetheless certain 
limitations to the study which must be considered. Owing to the experimental design, a 
blinded observer microscopically examined all the histological sections, resulting in an 
unpredictable and unevenly distributed number of airways available for analysis for each 
subject horse at both time periods. As well, due to the high interindividual variation in 
subepithelial area collagen content observed between airways, a greater sample number 
may have revealed greater changes than those obtained.  
Histological and morphometric analyses allow a general appreciation of different 
connective tissue remodeling events in the lung; they do not, however, give information on 
the biological or secretory activity of ECM cells at the time the sample is acquired. 
Additionally, the picrosirius-red staining procedure does not permit the differentiation of 
collagen type or fiber thickness. Immunohistochemical techniques specific for collagen 
types or cellular constituents of the ECM could offer complementary information as to the 
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type of fibers present in the subepithelial area of the airway as well as the biological 
activity of cells responsible for their synthesis, respectively.  
Future investigations into airway remodelling of other matrix constituents in 
heaves-affected horses; elastic fibers and glycosaminoglycans, for example, will be 
necessary as these components are known to be important in asthmatics and small animal 
models of human asthma. 
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ANNEXE A 
xvii 
IMAGE J® PROTOCOL FOR MORPHOMETRIC ANALYSIS OF EQUINE 
PERIPHERAL AIRWAYS  
 
 
 
 
 
 
 
Calibration (measurement comparison) 
 
1. Using the tool STRAIGHT LINE SELECTIONS, trace a known distance on the 
image of the stage micrometer at a given magnification (10X or 20X). 
 
2. Go to ANALYZE, click on SET SCALE and enter the known distance (Ex. in µm, 
in mm, or in cm). 
 
3. Select the GLOBAL option in the designated box. 
 
 
xviii 
 
 
 
4. Go to ANALYZE, and then click on TOOLS, and then click on SCALE BAR. 
  
5. Choose the LOCATION and COLOR of the scale bar if desired. 
 
6. Transpose the SCALE on the image in its designated location by re-clicking on  
SCALE BAR 
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Cutting or extracting a part of the image  
  
1. Example: Removing the airway smooth muscle layer and advential connective 
tissue from the rest of the airway image. Using the image in its original color 
format, select FREEHAND SELECTIONS, and using the TRACING TOOL, 
delimitate the region to extract. 
 
2. Choose EDIT and click on CLEAR OUTSIDE. 
 
3. Choosing EDIT and clicking on CLEAR performs the opposite, the part of the 
image interior to the region delimitated will be removed. 
 
 
 
 
 
Measuring a perimeter 
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1. Example:  Measuring the internal perimeter of the epithelium layer of the airway. 
Choose STRAIGHT LINE SELECTIONS, perform a right click on the mouse 
and select FREEHAND LINES. 
 
2. Trace the internal border of the epithelium by holding the left click on the mouse. 
 
3. Go to ANALYZE, followed by a click on MEASURE. 
 
 
 
 
 
4. The MEASURE option gives various information including the length of line 
selection, according to calibrated units. 
 
5. To change or increase the number of measurement parameters, go to ANALYZE, 
and choose SET MEASURMENTS. 
6.  Once the SET MEASUREMENTS window unfolds on the screen, click on the 
desired parameters such as area, density etc. 
  
7. Verify that the SCALE BAR is well calibrated depending on the magnification 
strength of the image. Otherwise, perimeter measurements will be erroneous.   
 
 
To add written text in an image 
 
 
1. Example: To write that the internal airway perimeter is 2, 70 mm in length beside 
the image. 
 
2. Click on TEXT TOOL and a text rectangle will appear on the image, using the 
mouse this rectangle can be moved to a designated location. 
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3. Once at the designated location, the desired information can be entered in the 
rectangle (ex. Internal perimeter = 2, 70 mm) and ctrl + D function can be used to 
insert the information. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Using the wand tool for automatic trace selection of an image area  
(Will work better in 8 BIT mode or in THRESHOLD COLOR mode)  
 
 
1. Select the WAND TOOL in the tool bar. 
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2. Place the WAND TOOL at the edge of a border of the region of interest in the 
image (Example: collagen of the subepithelial layer). The wand tool will 
automatically trace and highlight the region of interest. 
 
3. By clicking on the left cursor of the mouse and pressing the SHIFT key on the 
keyboard at the same time, other image areas can be traced and added to the initial 
wand selection. 
 
 
 
Data storage using the ROI MANAGER tool 
 
 
1. Go to ANALYZE, then choose TOOLS, and then choose ROI MANAGER. 
 
2. ROI MANAGER allows add-ins of additional traced regions in the image, which 
for example, were not picked up with the WAND TOOL on first try.  
 
 
 
 
 
3. A measurement can also be made directly in the ROI MANAGER by clicking on 
MEASURE. This will give desired parameters such as an area, perimeter etc.  
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4. In order to verify that the traced selections are correct (and that no subepithelial area 
has been forgotten for example), by pressing the DELETE key on the keyboard, the 
entire traced selection will disappear from the image and allow such as assessment. 
 
5. By pressing UNDO or (crtl + z) on the keyboard; the traced selection can be made 
to re-appear. 
 
6. To fill the selection with another color on the image, select FILL. 
 
7. The ROI MANAGER cannot add stored measures together, this must be done 
manually. 
 
8. Another way to measure the traced selections is by choosing ANALYZE in the tool 
menu, and then choosing MEASURE, as explained previously. 
 
  
Background correction 
 
 
1. Choose PLUGINS from the tool menu, then choose COLOUR FUNCTIONS, 
and then choose COLOUR BALANCE.  
 
2. Choose a sample from the image background to be corrected; it will be 
converted to a whiter shade. All images can then be standardized with the same 
background.  
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Threshold colour (Method 1) 
 
 
1. Go to IMAGE, select TYPE and choose the 8 BIT option. This will convert the 
image in black and white. 
 
2.  Go to IMAGE again, choose ADJUST, and then choose THRESHOLD. The 
image can then be thresholded in various ways with the BLACK AND WHITE, 
RED, or OVER AND UNDER options. 
3.  
4. These threshold options allow differentiation of colors in an image. This can be 
achieved by scrolling down the intensity bar with the mouse cursor.  
 
5. A THRESHOLD COLOUR plug-in exists which can give more specific colour 
differentiation and is detailed below. 
 
 
 
 
Thresholding colour (Method 2) 
 
 
1. Go to PLUGINS, then choose THRESHOLD COLOUR and then choose 
again THRESHOLD COLOUR. 
 
2. Choose a sample of the colour that needs to be thresholded. (Example: to sample 
the subepithelial collagen stained red). 
 
3. Click on SAMPLE, and only that thresholded colour will remain on the image.  
 
4. Click on THRESHOLD, and the selection will appear in black. 
 
5. Click on ORIGINAL for the image the resume its initial appearance.  
 
6. Once the selected colour has been thresholded, the ROI MANAGER can be 
opened as previously described. 
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7. Using the WAND TOOL and SHIFT key, desired image areas can be selected, 
and using ADD INS, can be grouped together in the ROI MANAGER. 
Thereafter, measurements can be obtained.  
 
8. It is possible to highlight the area selections in the ROI MANAGER, and 
superimpose the latter on the original image, and thus verify the success of the 
colour threshold for a given area. 
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ANNEXE B 
xxvii 
PICROSIRIUS-RED STAINING PROTOCOL FOR 
COLLAGEN FIBERS 
Reagents Required:  
 
0.05 M phosphate buffer12
 
  
0.5% papain solution13
0.1% picro-sirius red
  
14
Staining Procedure:  
  
1. Dewax section in toluene for 5 minutes  
2. Dehydrate for 2 minutes in 100% ethanol solution 
3. Dehydrate for 2 minutes in 95% ethanol solution 
4. Dehydrate for 2 minutes in 80% ethanol solution 
5. Wash in running tap water for 25 minutes.  
6. Wash in a few changes of distilled water.  
7. Wash in phosphate buffer (pH 4.7 and 0.05 M).  
8. Incubate at 37°C in 0.5% papain (pre-warmed) solution pH 4.4 for 90 minutes.  
9. Wash in a few changes of distilled water.  
10. Place slides in 0.1% picro-sirius red for 60 minutes.  
11. Wash in 0.01 N HCl for 2 minutes.  
12. Dehydrate for 2 minutes in 95% ethanol solution 
13. Dehydrate for 3 minutes in 100% ethanol 
14. Wash in toluene for 5 minutes 
Slides were then covered with a coverslip and left to dry overnight. 
                                                 
12 Fisher S-244 Lot 870519 Na2S2O5 
13 Aerus organics company  Code 416765000, CAS: 9001-73-4, EC:232-627-2, lot: AO218172001 
14 Direct Red:  Alfa Aesar Company, Direct Red 80 code 2610-10-8 FW 1373-09EINECS B211693, lot 10114582 
